No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
23682 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
4666 |
6. Filter based on genotype QC (FinnGen only) |
4666 |
Control definitions (FinnGen only)
- Control conditions
- not J10_COPDNAS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
COPD-related respiratory insufficiency
based on the number of shared cases.
Similar with more cases:
- COPD, early/later onset
- Other chronic obstructive pulmonary disease
- COPD
- Other chronic obstructive pulmonary disease, including avohilmo
- Chronic lower respiratory diseases
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 30357 | 10179 | 19634 |
| Only index persons | 22108 | 8032 | 14076 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.46 | 0.29 | 0.55 |
| Only index persons | 0.45 | 0.30 | 0.54 |
| Median age at first event (years) | |||
| Whole population | 70.82 | 70.93 | 70.75 |
| Only index persons | 70.60 | 70.78 | 70.50 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4666 | 1360 | 3306 |
| Unadjusted period prevalence (%) | 1.17 | 0.46 | 1.46 |
| Median age at first event (years) | 70.88 | 68.14 | 72.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4115
- Matched controls
- 41149
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
617.0
323.0
1454
37
WX722
NOMESCO Finland
PEEP
18.8
323.0
1279
964
R06.0
ICD-10 Finland
Dyspnoea
5.4
323.0
2044
6326
J45.9
ICD-10 Finland
Asthma, unspecified
6.7
323.0
1482
3197
R03AK06
ATC
salmeterol and fluticasone; inhalant
16.7
323.0
2030
2262
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1029.0
323.0
3675
327
R03AC02
ATC
salbutamol; inhalant
10.2
323.0
3318
11932
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
75.1
323.0
565
87
H02AB06
ATC
prednisolone; systemic
8.5
323.0
3249
12562
R95
ICPC
Chron obstructive pulmonary disease
63.6
323.0
772
149
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.5
323.0
2517
8053
J96.1
ICD-10 Finland
Chronic respiratory failure
193.5
323.0
1833
170
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
15.5
323.0
2395
3400
XG466
NOMESCO Finland
Sleep oxymetry
20.0
323.0
753
455
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
538.1
323.0
2040
75
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.7
323.0
1152
2249
R03AC12
ATC
salmeterol; inhalant
11.9
323.0
643
628
C03CA01
ATC
furosemide; systemic
6.5
323.0
2906
11044
R03BB01
ATC
ipratropium bromide; inhalant
12.7
323.0
717
674
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
15.0
323.0
1077
951
R03DA04
ATC
theophylline; systemic, rectal
16.6
323.0
1086
872
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.0
323.0
1710
4365
R03BB04
ATC
tiotropium bromide; inhalant
55.5
323.0
2586
1215
WX725
NOMESCO Finland
Noninvasive ventilation
19.4
323.0
1049
714
R03AK07
ATC
formoterol and budesonide; inhalant
6.0
323.0
1350
3075
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
42.4
323.0
501
134
I50.9
ICD-10 Finland
Heart failure, unspecified
5.6
323.0
1763
4844
R5140
NOMESCO Finland
Monitoring the use of the aid
5.9
323.0
1041
2217
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
10.5
323.0
776
889
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
318.9
323.0
1648
86
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
43.6
322.5
403
102
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
320.6
2639
13700
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.5
314.1
912
1722
R03BA05
ATC
fluticasone; inhalant
4.8
307.7
1209
3254
I50.0
ICD-10 Finland
Congestive heart failure
5.3
286.2
1005
2369
XG410
NOMESCO Finland
Flow-volume spirometry
10.5
283.4
587
644
TPH07
NOMESCO Finland
Cathetrisation of artery
5.0
277.2
1026
2554
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
16.8
271.5
448
297
R02
ICPC
Shortness of breath/dyspnoea
5.0
267.4
981
2408
H02AB07
ATC
prednisone; oral
4.5
263.4
1117
3178
G47.3
ICD-10 Finland
Sleep apnoea
3.8
259.5
1387
4859
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.9
256.9
961
2397
R03BA02
ATC
budesonide; inhalant
4.4
255.7
1098
3150
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
36.4
255.4
332
99
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
52.5
254.7
307
63
WX730
NOMESCO Finland
Conventional respirator
16.5
254.1
422
283
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
250.0
1461
5476
J01MA14
ATC
moxifloxacin; systemic
5.5
245.6
815
1770
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
244.9
1377
4985
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.9
238.2
1193
3904
J96.0
ICD-10 Finland
Acute respiratory failure
21.2
234.9
355
182
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.8
233.7
737
1499
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.0
232.0
2264
12055
J43.9
ICD-10 Finland
Emphysema, unspecified
23.3
231.1
339
158
WX892
NOMESCO Finland
Monitored bed care
5.3
225.5
771
1719
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.7
222.8
862
2194
J01MA12
ATC
levofloxacin; systemic
3.4
222.3
1361
5195
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.7
219.6
1191
4124
R03AC13
ATC
formoterol; inhalant
8.5
218.5
507
666
J45.1
ICD-10 Finland
Nonallergic asthma
6.8
218.4
596
999
C07AB07
ATC
bisoprolol; oral
2.9
216.2
2718
16669
J01AA02
ATC
doxycycline; systemic
3.4
216.0
3423
24485
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
41.5
212.3
268
69
R03BA01
ATC
beclometasone; inhalant
4.3
211.6
916
2591
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
42.7
210.4
264
66
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
53.6
209.8
252
50
C03DA01
ATC
spironolactone; oral
4.1
209.6
961
2864
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
207.0
197
*
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
31.0
199.9
270
93
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.0
196.6
912
2729
348
Kela drug reimbursment
Roflumilast
1871.7
196.3
189
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.8
187.4
509
839
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
176.2
1212
4883
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
10.0
173.4
363
394
R03DX07
ATC
roflumilast; oral
1775.6
169.9
164
*
R03AC03
ATC
terbutaline; inhalant
3.9
165.3
785
2362
H02AB04
ATC
methylprednisolone; systemic
3.4
151.3
861
2977
R03AC18
ATC
indacaterol; inhalant
49.4
147.8
180
38
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
147.5
496
1054
J45.8
ICD-10 Finland
Mixed asthma
9.8
147.2
311
341
J01FA06
ATC
roxithromycin; oral
2.4
142.9
1840
10414
A02BC02
ATC
pantoprazole; systemic
2.3
138.4
2839
20034
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
28.8
134.8
185
67
R03DC03
ATC
montelukast; oral
3.4
134.2
731
2424
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
131.8
1161
5303
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.9
131.5
463
1029
J46
ICD-10 Finland
Status asthmaticus
10.2
130.0
267
277
TKC20
NOMESCO Finland
Catheterisation of bladder
3.6
129.7
670
2126
N07BA03
ATC
varenicline; oral
7.7
129.7
318
445
Z2446
NOMESCO Finland
Social worker
4.8
126.9
460
1053
E66.01
ICD-10 Finland
Obesity due to excess calories
5.4
126.9
408
818
J96.9
ICD-10 Finland
Respiratory failure, unspecified
27.9
125.7
174
65
GD1AD
NOMESCO Finland
Thorax CT examination
5.4
124.6
400
800
WX704
NOMESCO Finland
Intubation
4.2
118.8
497
1307
R28
ICPC
Limited function/disability (R)
15.1
118.2
201
139
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.0
117.6
804
3109
XG460
NOMESCO Finland
Short time oxymetry
10.1
117.0
242
254
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.1
116.4
299
447
Z3226
NOMESCO Finland
Physiotherapist
2.6
114.8
998
4465
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
113.0
108
*
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
86.7
112.8
126
15
A46
ICD-10 Finland
Erysipelas
2.7
108.5
887
3813
WX882
NOMESCO Finland
High dependency care
6.2
107.4
306
526
ZXD05
NOMESCO Finland
Urgent procedure
2.2
107.0
1507
8559
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
81.7
105.8
119
15
R96
ICPC
Asthma
3.8
102.5
484
1409
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
101.6
1197
6221
C01AA05
ATC
digoxin; systemic
2.8
99.7
722
2866
R4110
NOMESCO Finland
Physiotherapy
2.2
98.8
1267
6837
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
13.2
93.5
168
132
R03AK08
ATC
formoterol and beclometasone; inhalant
6.6
93.5
253
405
I50.1
ICD-10 Finland
Left ventricular failure
3.6
93.2
463
1401
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
92.5
740
3109
E66.00
ICD-10 Finland
Metabolic syndrome
4.6
92.4
346
810
Z3231
NOMESCO Finland
Registered nurse
2.1
91.9
1351
7693
N02AX02
ATC
tramadol; systemic, rectal
2.0
90.7
1911
12566
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
89.1
1303
7382
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
88.5
1461
8701
J01CA04
ATC
amoxicillin; systemic
2.0
87.9
3000
23525
WX721
NOMESCO Finland
Oxygen concentrator therapy
78.1
87.5
99
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
86.3
737
3200
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
86.1
1396
8231
R03BB07
ATC
umeclidinium bromide; inhalant
30.8
84.9
114
38
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.9
82.6
242
429
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
82.2
427
1333
SPAT1254
SPAT
Administration of medicine
2.4
81.8
821
3878
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.0
80.8
1472
9033
I50
ICD-10 Finland
Heart failure
4.3
80.3
315
770
A28
ICPC
Limited function/disability NOS
2.3
80.2
936
4753
WX872
NOMESCO Finland
Intensive care
3.6
80.2
389
1149
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
79.9
1304
7656
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
79.7
1474
9087
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
20.6
79.5
120
60
A06AD11
ATC
lactulose; oral
2.3
79.2
924
4690
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.5
78.7
298
703
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.8
78.7
278
611
R60.0
ICD-10 Finland
Localized oedema
2.6
78.5
633
2648
Z72.0
ICD-10 Finland
Tobacco use
8.1
78.4
183
235
R04.2
ICD-10 Finland
Haemoptysis
4.6
78.2
290
670
J01FF01
ATC
clindamycin; systemic
2.1
77.8
1179
6703
B01AA03
ATC
warfarin; systemic
2.0
76.9
1353
8153
J45
ICD-10 Finland
Asthma
3.2
76.9
438
1462
R06.2
ICD-10 Finland
Wheezing
4.8
75.4
264
574
N05CF01
ATC
zopiclone; oral
1.9
74.6
1537
9797
R03AK11
ATC
formoterol and fluticasone; inhalant
7.5
73.7
180
248
E66.8
ICD-10 Finland
Other obesity
5.2
73.3
241
489
ZX120
NOMESCO Finland
Intravenous
2.8
72.9
540
2140
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.8
72.4
333
938
E66.9
ICD-10 Finland
Obesity, unspecified
6.2
72.0
202
338
Z2221
NOMESCO Finland
Medical doctor
2.0
71.8
1191
6976
XG405
NOMESCO Finland
Education on PEF monitoring
9.9
71.7
148
154
N02AA05
ATC
oxycodone; systemic
2.2
71.6
852
4338
SPAT1262
SPAT
Handing over of treatment supplies
2.1
71.5
964
5183
A07AA02
ATC
nystatin; oral
3.4
71.4
374
1170
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.5
69.9
218
416
SPAT1059
SPAT
Spirometry at the office
3.8
69.2
316
884
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
68.8
612
2690
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
68.6
780
3876
J47
ICD-10 Finland
Bronchiectasis
7.2
67.7
170
244
C01DA14
ATC
isosorbide mononitrate; oral
2.0
67.2
1098
6361
J01DA01
ATC
[U] cefalexin; systemic
1.8
66.6
2457
18741
RK320
NOMESCO Finland
NA
11.0
66.5
130
122
R03BB06
ATC
glycopyrronium bromide; inhalant
36.1
65.9
85
24
A02BC01
ATC
omeprazole; systemic
1.9
65.7
1279
7896
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.4
64.9
204
393
M04AA01
ATC
allopurinol; systemic
2.1
63.7
851
4529
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.2
62.5
352
1160
127
Kela drug reimbursment
Transplant complication
8.4
62.4
141
172
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
15.1
62.4
105
71
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
61.6
687
3364
R03AC19
ATC
olodaterol; inhalant
36.6
61.5
79
22
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.2
61.1
344
1132
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
60.5
751
3860
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.1
59.9
198
404
R03BB02
ATC
oxitropium bromide; inhalant
14.2
59.7
103
74
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
59.1
1126
6847
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
59.1
358
1240
S97
ICPC
Chronic ulcer skin
3.1
58.4
353
1219
R05CB01
ATC
acetylcysteine; inhalant, oral
6.6
57.0
152
238
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
56.4
480
2044
N05BA01
ATC
diazepam; systemic, rectal
2.3
56.2
607
2921
N03AX16
ATC
pregabalin; oral
1.9
56.1
953
5542
J43.8
ICD-10 Finland
Other emphysema
52.3
56.0
67
13
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.9
56.0
1017
6058
L28
ICPC
Limited function/disability (L)
2.0
55.9
810
4427
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
24.0
55.9
80
34
N05AA02
ATC
levomepromazine; systemic
3.8
55.9
252
696
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
55.7
453
1883
N06AX11
ATC
mirtazapine; oral
1.8
55.4
1201
7602
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
55.2
407
1595
TGC00
NOMESCO Finland
Bronchial lavation
4.7
55.2
196
432
C09AA05
ATC
ramipril; oral
1.8
55.2
1313
8567
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.1
54.7
223
563
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
54.5
433
1773
N05CD07
ATC
temazepam; oral
2.1
54.5
711
3719
N05BA04
ATC
oxazepam; oral
1.9
54.5
994
5921
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
54.3
52
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
54.2
1288
8385
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
6.0
53.9
155
268
M05BA04
ATC
alendronic acid; oral
2.6
53.9
419
1693
A10BA02
ATC
metformin; oral
1.8
53.7
1354
8977
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
62.9
53.4
62
10
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.9
53.1
155
273
T90
ICPC
Diabetes non-insulin dependent
1.8
52.9
1083
6705
Z94.2
ICD-10 Finland
Lung transplant status
115.6
52.9
57
5
A02BC03
ATC
lansoprazole; oral
1.8
52.8
1256
8167
N06AB04
ATC
citalopram; systemic
2.0
52.4
851
4847
SPAT1060
SPAT
Administration of oxygen
17.8
52.0
82
47
J01DB01
ATC
cefalexin; oral
1.7
51.9
3043
25576
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.6
51.2
398
1608
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
11.4
50.9
97
87
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
50.7
880
5128
L04AA06
ATC
mycophenolic acid; systemic
6.6
50.0
132
204
RK110
NOMESCO Finland
NA
10.5
50.0
99
96
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.3
49.9
106
117
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
49.9
200
497
R03BA08
ATC
ciclesonide; inhalant
2.9
48.6
314
1131
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
32.5
48.6
64
20
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
48.5
381
1546
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.6
48.5
236
693
TK800
NOMESCO Finland
Hemodialysis
4.6
48.3
175
394
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
7.9
48.2
113
147
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
47.8
1314
8869
J01FA09
ATC
clarithromycin; systemic
1.8
47.4
1027
6437
AA1AD
NOMESCO Finland
CT of head and brain
1.8
47.3
1125
7258
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
9.7
46.4
96
101
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
45.9
431
1924
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
45.9
291
1036
A01AB09
ATC
miconazole; local oral
2.5
45.8
395
1686
GDG10
NOMESCO Finland
Bilateral transplantation of lung
101.2
45.8
50
5
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.4
45.8
171
397
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
45.6
275
946
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
45.6
1590
11428
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
45.6
264
881
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
45.4
1276
8634
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.1
45.3
260
864
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
45.3
516
2526
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
45.2
389
1660
A10AE04
ATC
insulin glargine; parenteral
2.2
44.9
481
2287
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
44.9
342
1360
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.2
44.9
245
786
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
44.5
499
2425
SPAT1263
SPAT
Sampling
1.6
44.4
1616
11726
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.6
44.0
157
348
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
43.9
226
694
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
16.9
43.7
70
42
RS221
NOMESCO Finland
NA
7.0
43.7
111
163
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
43.6
309
1177
R03BB05
ATC
aclidinium bromide; inhalant
28.5
43.4
59
21
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
42.9
250
839
N05AH04
ATC
quetiapine; oral
2.1
42.8
569
2972
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
42.8
487
2379
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.5
42.8
212
632
A12BA01
ATC
potassium chloride; oral
2.6
42.7
327
1306
AN1
HP
Coronary angiography
1.9
42.5
692
3910
RK250
NOMESCO Finland
NA
13.7
42.4
74
55
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
42.4
291
1087
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
42.3
387
1703
J42
ICD-10 Finland
Unspecified chronic bronchitis
6.6
42.2
111
171
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
42.1
252
862
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.8
41.9
144
307
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
41.8
392
1746
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
41.7
287
1075
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
41.4
617
3371
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.4
41.4
157
370
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.2
41.4
115
191
R81
ICPC
Pneumonia
3.6
41.3
197
569
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
41.0
291
1111
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
40.7
1625
11989
J20
ICD-10 Finland
Acute bronchitis
2.4
40.7
384
1714
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
40.4
649
3641
R05FB02
ATC
cough suppressants and expectorants
1.6
40.3
1497
10835
R03DC01
ATC
zafirlukast; oral
6.2
40.3
112
186
WW200
NOMESCO Finland
Immunization
4.3
40.1
155
372
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.4
40.1
150
349
M10.9
ICD-10 Finland
Gout, unspecified
2.3
39.3
401
1861
A02BA02
ATC
ranitidine; systemic
1.7
39.2
906
5739
ZX108
NOMESCO Finland
Inhalation
10.3
39.1
78
77
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
38.6
1097
7377
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
38.6
1037
6868
J43.2
ICD-10 Finland
Centrilobular emphysema
24.8
38.4
54
22
J37.0
ICD-10 Finland
Chronic laryngitis
3.9
38.1
165
440
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.8
38.0
170
466
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
72.5
38.0
43
6
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
37.7
555
3009
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
37.5
502
8293
ZXE00
NOMESCO Finland
One hour or less
1.6
37.2
1480
10839
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
37.2
348
1544
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
11.1
37.1
71
65
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.2
37.0
102
168
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
37.0
1247
8759
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
36.9
594
3329
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.1
36.8
209
689
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.0
36.7
224
776
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.4
36.6
185
560
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
4.0
36.3
152
394
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
36.2
231
825
P17
ICPC
Tobacco abuse
9.1
36.2
77
86
GX2C5
NOMESCO Finland
Short-lasting oximetry
68.9
36.0
41
6
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
35.5
201
659
N05AH03
ATC
olanzapine; systemic
3.0
35.5
212
724
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
35.5
632
3665
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
35.5
332
1474
J01DA06
ATC
[U] cefuroxime; systemic
1.9
35.3
545
3004
N02BE01
ATC
paracetamol; systemic, rectal
1.6
35.2
3237
28625
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
35.0
701
4230
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
34.8
394
1915
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
34.7
221
787
R29
ICPC
Respiratory symptom/complaint other
2.7
34.6
251
970
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
34.6
2548
21331
5CM18
NOMESCO Finland
NA
9.6
34.4
71
75
R04
ICPC
Breathing problem other
3.6
34.2
162
466
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
10.8
34.1
66
62
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
34.0
328
1479
E000001
ATC
NA
1.7
33.7
734
4540
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.7
33.5
73
85
F20.9
ICD-10 Finland
Schizophrenia, unspecified
5.7
33.4
98
175
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
33.3
718
4424
J01MA02
ATC
ciprofloxacin; systemic
1.5
33.2
1635
12488
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.8
33.1
221
812
R06AE07
ATC
cetirizine; oral
1.6
32.9
1301
9440
J01FA15
ATC
telithromycin; oral
2.2
32.9
350
1652
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.6
32.7
155
446
I42.0
ICD-10 Finland
Dilated cardiomyopathy
3.1
32.5
184
604
207
Kela drug reimbursment
Chronic arrhythmias
1.7
31.8
765
4866
K77
ICPC
Heart failure
3.5
31.8
153
446
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
31.6
200
711
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.9
31.3
105
219
B01AC04
ATC
clopidogrel; oral
1.7
31.3
827
5399
WX002
NOMESCO Finland
Sedation and analgesia
1.7
31.1
802
5200
J15.8
ICD-10 Finland
Other bacterial pneumonia
8.3
30.9
69
84
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
30.8
343
1651
J43
ICD-10 Finland
Emphysema
85.7
30.7
34
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
30.7
185
636
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
30.5
159
493
A02BC05
ATC
esomeprazole; systemic
1.5
30.5
1422
10675
SPAT1255
SPAT
Intravenous administration of medicine
2.2
30.3
318
1491
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
30.2
157
486
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.7
30.1
218
839
R50.9
ICD-10 Finland
Fever, unspecified
1.8
29.9
570
3368
N06AX21
ATC
duloxetine; oral
2.2
29.9
334
1609
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.7
29.8
65
76
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
5.9
29.8
85
147
E0000UV
ATC
NA
1.5
29.8
1322
9800
P01AB01
ATC
metronidazole; oral, rectal
1.5
29.8
1261
9250
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.8
29.6
204
762
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.7
29.6
214
825
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.1
29.6
169
560
UJF32
NOMESCO Finland
Coloscopy
1.6
29.5
1049
7384
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.0
29.5
394
2048
Z51.5
ICD-10 Finland
Palliative care
2.1
29.4
337
1641
C08CA01
ATC
amlodipine; oral
1.5
29.4
1565
12058
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.1
29.3
62
69
SPAT1058
SPAT
PEF monitoring instruction
2.2
29.1
319
1525
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
29.0
333
1623
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
28.8
228
926
A10BH01
ATC
sitagliptin; oral
1.9
28.8
443
2429
N06AB10
ATC
escitalopram; oral
1.8
28.7
534
3125
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
28.7
726
4668
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
7.9
28.6
66
85
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.8
28.5
125
338
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
28.5
275
1235
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
28.5
936
6450
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
28.4
1273
9429
R05
ICPC
Cough
1.7
28.4
722
4647
N07BB01
ATC
disulfiram; oral
3.1
28.4
164
548
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.0
28.4
172
594
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.8
28.4
97
207
J43.1
ICD-10 Finland
Panlobular emphysema
48.9
28.4
34
7
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.1
28.4
343
1708
N06AX16
ATC
venlafaxine; oral
2.0
28.3
371
1911
WX720
NOMESCO Finland
Own respiration
2.9
28.3
184
664
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
28.2
187
682
N06AA09
ATC
amitriptyline; systemic
2.0
28.2
392
2069
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
31.1
28.1
37
12
N03AG01
ATC
valproic acid; systemic, rectal
2.5
28.1
231
958
L04AD01
ATC
ciclosporin; systemic
4.7
28.1
98
214
WX890
NOMESCO Finland
Intesive care monitoring
5.8
28.0
81
143
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
5.3
27.6
86
166
J98.1
ICD-10 Finland
Pulmonary collapse
7.4
27.6
66
90
A10BH05
ATC
linagliptin; oral
2.3
27.5
266
1196
A02BA04
ATC
nizatidine; systemic
2.0
27.5
379
1992
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
27.3
413
2247
PE1AT
NOMESCO Finland
Femoral artery PTA
4.7
27.3
95
207
B01AB05
ATC
enoxaparin; parenteral
1.5
27.3
1180
8660
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.9
27.3
115
301
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
27.1
1149
8389
4168X
ICD-9 Finland
Chronic pulmonary heart disease, Other chronic pulmonary heart diseases
+∞
27.1
26
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
27.1
314
1537
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.0
27.0
88
179
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
20.2
26.9
40
20
N05AF03
ATC
chlorprothixene; systemic
3.9
26.8
113
296
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
26.7
1048
7518
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
26.7
201
792
A08
ICPC
Swelling
2.6
26.7
198
775
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.4
26.3
237
1031
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
26.2
222
936
N05AH02
ATC
clozapine; systemic
7.0
26.1
65
94
K05.31
ICD-10 Finland
Periodontitis pronounced
1.9
26.0
389
2106
A11CC03
ATC
alfacalcidol; systemic
3.2
26.0
139
441
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
25.9
459
2640
A04
ICPC
Weakness/tiredness general
1.8
25.8
497
2939
RK310
NOMESCO Finland
NA
40.3
25.8
32
8
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.7
25.4
55
64
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
25.3
288
1398
R03DA05
ATC
aminophylline; systemic, rectal
6.4
25.3
67
106
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
25.2
219
936
TK810
NOMESCO Finland
Hemofiltration
6.9
25.2
63
92
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
25.2
147
496
N02AA01
ATC
morphine; systemic, rectal
3.7
25.1
111
303
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
25.1
243
1095
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
25.1
612
3883
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
15.3
25.0
41
27
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
25.0
144
481
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
24.9
251
1151
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.2
24.8
95
228
N03AX12
ATC
gabapentin; oral
1.7
24.7
532
3253
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.2
24.6
267
1268
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.9
24.6
82
171
N19
ICD-10 Finland
Unspecified kidney failure
2.4
24.6
218
941
E87.6
ICD-10 Finland
Hypokalaemia
3.0
24.6
147
503
B01AF02
ATC
apixaban; oral
1.8
24.6
457
2668
R99
ICPC
Respiratory disease other
4.1
24.6
97
240
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
24.5
518
3149
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
24.4
901
6350
XF404
NOMESCO Finland
Ambulatory ECG
1.8
24.4
420
2388
N06AX03
ATC
mianserin; oral
2.4
24.3
210
894
K07
ICPC
Swollen ankles/oedema
2.4
24.2
220
959
N06AA12
ATC
doxepin; systemic
2.3
24.2
239
1086
ZXA00
NOMESCO Finland
Right side
1.5
24.2
1082
7957
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
24.1
1158
8642
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.6
24.1
182
720
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.2
24.1
132
427
GX2D5
NOMESCO Finland
Sleep oximetry
12.4
24.0
43
35
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
23.9
181
717
A10BB12
ATC
glimepiride; oral
1.8
23.9
412
2345
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.3
23.8
90
214
J01FA10
ATC
azithromycin; systemic
1.4
23.8
1600
12745
N05AA01
ATC
chlorpromazine; systemic, rectal
5.4
23.6
72
136
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.4
23.6
118
357
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.8
23.5
79
167
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.1
23.4
131
430
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.7
23.4
103
281
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.8
23.3
101
272
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
3.5
23.2
111
324
E87.5
ICD-10 Finland
Hyperkalaemia
3.4
23.2
116
351
R53
ICD-10 Finland
Malaise and fatigue
1.6
23.2
766
5252
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.2
23.1
88
211
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.3
23.1
51
62
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
54.3
23.0
27
5
1CX08
NOMESCO Finland
NA
7.6
23.0
54
72
R78
ICPC
Acute bronchitis/bronchiolitis
3.6
22.9
106
301
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.6
22.9
106
302
N06AB03
ATC
fluoxetine; oral
1.8
22.8
389
2204
A01AB04
ATC
amphotericin B; local oral
2.3
22.8
216
961
E66
ICD-10 Finland
Obesity
3.0
22.8
134
455
A03
ICPC
Fever
1.8
22.8
405
2329
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
22.7
73
1978
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
22.6
243
1151
RS220
NOMESCO Finland
NA
4.8
22.6
76
161
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
22.5
115
354
A10BJ02
ATC
liraglutide; parenteral
3.6
22.5
104
296
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
22.4
1127
8462
A10AE05
ATC
insulin detemir; parenteral
2.2
22.3
233
1088
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
22.2
314
1661
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
3.0
22.2
134
462
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.0
22.1
55
80
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
3.1
22.0
126
419
XA420
NOMESCO Finland
Extensive sleep examination
5.6
21.8
64
116
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
3.3
21.8
110
335
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.9
21.8
136
479
Z94.0
ICD-10 Finland
Kidney transplant status
5.1
21.8
69
137
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
21.7
177
729
R33
ICD-10 Finland
Retention of urine
1.7
21.7
484
2986
JN4AD
NOMESCO Finland
Body CT examination
1.9
21.7
335
1835
I20.00
ICD-10 Finland
Unstable angina
2.3
21.6
203
901
R03CC02
ATC
salbutamol; systemic
3.4
21.5
106
317
N05BA02
ATC
chlordiazepoxide; systemic
3.1
21.5
120
394
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.4
21.4
107
324
M54.5
ICD-10 Finland
Low back pain
1.5
21.4
981
7218
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
21.3
185
791
N05AX12
ATC
aripiprazole; systemic
4.0
21.2
86
219
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
4.7
21.1
72
155
F61.0
ICD-10 Finland
Mixed personality disorders
5.8
21.1
60
105
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.3
21.1
199
884
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
20.9
394
2307
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
20.8
1357
10677
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.5
20.7
169
701
N06AB06
ATC
sertraline; oral
2.0
20.5
285
1500
D07AC01
ATC
betamethasone; topical
1.4
20.4
1191
9171
J86.9
ICD-10 Finland
Pyothorax without fistula
5.1
20.4
65
130
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.2
20.4
79
193
205
Kela drug reimbursment
Chronic hypertension
1.4
20.4
1380
10918
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
20.3
350
1988
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.4
20.3
174
737
L17
ICPC
Foot/toe symptom/complaint
1.5
20.3
845
6087
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
20.3
169
708
C10AA01
ATC
simvastatin; oral
1.4
20.2
1975
16615
N06DA02
ATC
donepezil; oral
0.4
20.1
68
1805
A98
ICPC
Health maint/preventive medicine
0.7
19.9
2824
31015
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
19.8
125
444
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.7
19.8
138
521
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
19.8
81
208
N05AC02
ATC
thioridazine; oral
3.6
19.8
89
248
ZXA05
NOMESCO Finland
Left side
1.4
19.8
993
7421
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.7
19.7
57
102
N06DX01
ATC
memantine; oral
0.4
19.7
97
2225
SPAT1104
SPAT
Monitoring of emergency patient
2.0
19.7
278
1472
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
8.1
19.7
44
55
I27.0
ICD-10 Finland
Primary pulmonary hypertension
13.2
19.6
34
26
C08DA01
ATC
verapamil; systemic
2.2
19.6
197
903
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
10.4
19.6
38
37
C08DB01
ATC
diltiazem; oral
1.9
19.5
313
1734
SPAT1172
SPAT
Guidance concerning hydration
2.7
19.5
133
498
N05BA12
ATC
alprazolam; oral
1.8
19.4
329
1858
D75.1
ICD-10 Finland
Secondary polycythaemia
6.9
19.4
48
70
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.5
19.4
42
50
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.3
19.3
97
296
S76
ICPC
Skin infection other
2.2
19.1
204
961
UJD02
NOMESCO Finland
Gastroscopy
2.1
19.1
216
1045
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.7
19.1
65
140
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
19.1
1047
7947
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
9.4
19.1
39
42
T82
ICPC
Obesity
3.0
19.0
110
370
XQ800
NOMESCO Finland
Prick test
2.3
19.0
173
758
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
4.1
19.0
74
182
49300
ICD-8 Finland
Asthma, bronchiale
3.0
18.9
111
378
GBB00
NOMESCO Finland
Tracheostomy
3.8
18.8
81
218
S10
ICPC
Boil/carbuncle
2.2
18.8
206
982
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.1
18.7
220
1084
JN4BD
NOMESCO Finland
Extensive body CT
1.6
18.7
466
2958
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
5.3
18.7
57
109
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.0
18.7
241
1230
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
18.6
363
2145
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
100.5
18.6
20
*
4169X
ICD-9 Finland
Chronic pulmonary heart disease, unspecified
190.8
18.5
19
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
18.5
757
10078
J93.9
ICD-10 Finland
Pneumothorax, unspecified
7.8
18.5
42
54
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
4.8
18.5
62
132
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
18.4
638
4397
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.5
18.4
66
150
3AC01
NOMESCO Finland
NA
4.7
18.3
62
133
RK323
NOMESCO Finland
NA
9.6
18.3
37
39
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.2
18.2
95
298
N18.0
ICD-10 Finland
End-stage renal disease
3.6
18.2
84
240
N17.8
ICD-10 Finland
Other acute renal failure
4.0
18.1
72
181
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
7.6
18.1
42
56
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.2
18.0
97
312
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.2
18.0
181
831
R4190
NOMESCO Finland
Nutritional therapy
2.8
18.0
115
414
R05CB03
ATC
carbocisteine; oral
2.9
18.0
110
385
SPAT1240
SPAT
Therapeutic discussion
2.0
17.9
225
1136
RS230
NOMESCO Finland
NA
8.1
17.9
40
50
R01AD09
ATC
mometasone; nasal
1.4
17.9
1237
9766
EBA00
NOMESCO Finland
Extraction of tooth
1.4
17.9
1010
7696
R04.0
ICD-10 Finland
Epistaxis
1.8
17.9
336
1963
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
17.9
260
1391
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.5
17.9
85
249
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.5
17.9
138
556
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
17.7
1218
9606
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.8
17.7
75
200
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.5
17.7
83
241
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
17.6
483
3142
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
17.6
1386
11173
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
17.6
602
4138
RF220
NOMESCO Finland
NA
3.7
17.6
78
216
X57
ICD-10 Finland
Unspecified privation
3.0
17.6
104
357
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.8
17.5
117
433
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
17.5
919
6903
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.5
17.5
82
238
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
3.5
17.4
81
233
E000003
ATC
NA
2.3
17.4
164
729
WZC30
NOMESCO Finland
Teaching
1.6
17.4
458
2951
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
17.4
321
1866
WX726
NOMESCO Finland
High-flow oxygen therapy
17.0
17.4
27
16
PD3AT
NOMESCO Finland
Pelvic artery PTA
6.1
17.4
47
78
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.1
17.3
208
1034
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.6
17.3
50
90
160
Kela drug reimbursment
exenatide
3.2
17.2
89
278
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.6
17.2
124
481
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
17.2
250
1338
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.1
17.1
94
307
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
17.1
148
632
SPAT1229
SPAT
Assessment of need for aid
1.7
17.1
349
2093
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
2.9
17.0
104
364
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.1
17.0
95
314
I45.9
ICD-10 Finland
Conduction disorder, unspecified
4.2
16.9
64
154
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.1
16.9
93
304
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
16.9
478
3137
M79.6
ICD-10 Finland
Pain in limb
1.4
16.8
1111
8687
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.8
16.8
109
397
N05AB03
ATC
perphenazine; systemic, rectal
2.5
16.7
128
514
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.7
16.7
72
195
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
16.7
121
471
SPF30
NOMESCO Finland
Soling for prothesis
2.9
16.7
103
364
TGA30
NOMESCO Finland
Thoracocentesis
4.4
16.6
60
138
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.0
16.6
221
1144
K08.3
ICD-10 Finland
Retained dental root
1.9
16.6
263
1454
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.3
16.4
39
54
RK123
NOMESCO Finland
NA
18.0
16.4
25
14
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
23.1
16.4
23
10
J02AC01
ATC
fluconazole; systemic
1.4
16.3
945
7216
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
16.2
331
1982
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.8
16.2
69
185
P15
ICPC
Chronic alcohol abuse
3.0
16.2
94
319
WNF00
NOMESCO Finland
Infection source and contact determination
6.0
16.1
44
74
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.9
16.1
67
176
SPAT1234
SPAT
Support of social functional capacity
1.9
16.1
226
1194
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.5
16.1
75
217
XF402
NOMESCO Finland
ECG with work load test
1.6
16.0
448
2928
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.1
16.0
177
849
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
8.2
16.0
35
43
XF622
NOMESCO Finland
Measurement of minute volume of heart
8.2
16.0
35
43
UKC02
NOMESCO Finland
Cystoscopy
1.4
16.0
794
5888
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
21.0
15.9
23
11
C09AA02
ATC
enalapril; systemic
1.4
15.9
907
6898
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
9.0
15.9
33
37
WX900
NOMESCO Finland
Resuscitation
5.0
15.9
50
100
I20.09
ICD-10 Finland
Unstable angina
1.8
15.8
293
1705
OAB43
SPAT
NA
0.3
15.8
34
1104
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.1
15.8
38
54
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
15.7
1011
7851
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
15.7
15.7
25
16
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.6
15.7
45
81
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
15.6
201
1026
R06.5
ICD-10 Finland
Mouth breathing
1.8
15.6
279
1605
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
4.9
15.6
50
102
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
7.6
15.6
36
48
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.9
15.6
232
1254
A01
ICPC
Pain general/multiple sites
1.8
15.6
260
1461
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
4.4
15.6
56
129
A41.8
ICD-10 Finland
Other specified sepsis
2.9
15.5
93
323
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.9
15.5
93
323
M05BA07
ATC
risedronic acid; oral
2.5
15.5
120
485
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
3.8
15.5
65
173
J01DA08
ATC
[U] cefaclor; oral
1.8
15.4
250
1392
RS222
NOMESCO Finland
NA
3.8
15.4
65
174
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
4.9
15.4
50
104
WX402
NOMESCO Finland
General anaesthesia
1.6
15.4
469
3133
L82
ICD-10 Finland
Seborrhoeic keratosis
0.6
15.3
233
3805
N30.0
ICD-10 Finland
Acute cystitis
1.6
15.3
410
2651
P03
ICPC
Feeling depressed
2.1
15.3
167
798
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
15.2
614
4363
A07AA09
ATC
vancomycin; oral
3.5
15.2
71
206
N06AX12
ATC
bupropion; oral
2.6
15.2
110
427
E86
ICD-10 Finland
Volume depletion
2.4
15.2
128
542
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.3
15.2
76
233
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
15.2
144
646
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
17.8
15.1
23
13
PEN23
NOMESCO Finland
Plastic repair of femoral artery
4.3
15.1
56
133
K92.0
ICD-10 Finland
Haematemesis
2.4
15.1
129
548
R13
ICD-10 Finland
Dysphagia
1.8
15.1
250
1402
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.6
14.9
112
444
K55.8
ICD-10 Finland
Other vascular disorders of intestine
5.7
14.9
42
74
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.3
14.9
75
231
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
3.7
14.9
64
174
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
14.8
519
3574
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
14.8
614
8210
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.4
14.8
128
549
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
3.9
14.8
60
155
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.2
14.8
56
136
K92.1
ICD-10 Finland
Melaena
1.8
14.8
255
1451
WX110
NOMESCO Finland
Local anesthesy
1.3
14.7
2087
18193
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
14.7
43
1214
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
14.7
230
1266
N03AX09
ATC
lamotrigine; oral
2.6
14.7
110
435
R79
ICPC
Chronic bronchitis
18.4
14.7
22
12
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
9.7
14.7
29
30
D07XC01
ATC
betamethasone, combinations; topical
1.6
14.6
436
2892
R10.0
ICD-10 Finland
Acute abdomen
2.5
14.6
115
470
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
4.8
14.6
48
101
RF210
NOMESCO Finland
NA
2.7
14.6
101
384
R05DB20
ATC
other cough suppressants - combinations
2.0
14.6
193
997
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
150.5
14.5
15
*
J01GB01
ATC
tobramycin; inhalant, parenteral
150.5
14.5
15
*
RK290
NOMESCO Finland
NA
8.4
14.5
31
37
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
14.4
234
1304
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
14.4
493
3377
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
8.9
14.4
30
34
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
14.4
246
1392
F34.1
ICD-10 Finland
Dysthymia
2.7
14.4
95
352
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
2.1
14.3
163
793
ZZA00
NOMESCO Finland
Split skin graft
2.2
14.3
143
655
SPAT1301
SPAT
No procedures
1.3
14.3
1126
9012
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
14.3
183
935
J81
ICD-10 Finland
Pulmonary oedema
4.4
14.3
51
117
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
14.3
23
868
N05AF05
ATC
zuclopenthixol; systemic
4.9
14.3
46
95
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.9
14.3
46
95
L57.0
ICD-10 Finland
Actinic keratosis
0.6
14.2
172
2978
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.7
14.2
98
372
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.4
14.2
126
545
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
14.2
271
1589
XA421
NOMESCO Finland
Nocturnal polygraphy
9.1
14.2
29
32
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.5
14.1
66
193
E66.0
ICD-10 Finland
Obesity due to excess calories
4.0
14.0
56
143
SPAT1216
SPAT
Assessment of functional ability
1.4
14.0
629
4561
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.2
14.0
74
237
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.3
14.0
128
566
R03AC04
ATC
fenoterol; inhalant
6.4
13.9
36
57
A12AA04
ATC
calcium carbonate; oral
2.9
13.9
86
305
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.9
13.9
208
1126
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
13.9
229
1282
RD210
NOMESCO Finland
NA
3.3
13.9
69
211
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
13.8
243
1388
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.7
13.8
96
367
XV5WT
NOMESCO Finland
NA
53.5
13.8
16
*
XX4BW
NOMESCO Finland
NA
11.4
13.8
25
22
R63.4
ICD-10 Finland
Abnormal weight loss
2.2
13.7
139
642
H25.8
ICD-10 Finland
Other senile cataract
1.5
13.7
493
3417
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.6
13.7
97
373
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.8
13.7
1087
13224
ZXA10
NOMESCO Finland
Bilateral
1.4
13.6
682
5050
ZPB22
NOMESCO Finland
Autograft of vein
5.0
13.6
43
87
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
2.7
13.6
91
340
WYA20
NOMESCO Finland
Home visit
2.8
13.6
89
327
30180
ICD-8 Finland
Personality disorders, Immatura
7.6
13.6
31
41
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
13.5
222
1239
N05AB01
ATC
dixyrazine; systemic
3.4
13.5
65
194
R11
ICD-10 Finland
Nausea and vomiting
1.8
13.5
251
1461
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.1
13.5
152
737
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
3.8
13.4
56
149
N05BB01
ATC
hydroxyzine; systemic
1.9
13.4
210
1157
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.1
13.4
51
125
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
13.4
127
571
J01CF05
ATC
flucloxacillin; systemic
2.2
13.3
134
618
XG420
NOMESCO Finland
Time-volume spirometry
21.2
13.3
19
9
M10
ICD-10 Finland
Gout
1.9
13.3
205
1123
PDQ22
NOMESCO Finland
Insertion of endovascular graft into a. iliaca externa
11.5
13.3
24
21
N05BE01
ATC
buspirone; oral
2.6
13.3
95
369
A01AB10
ATC
natamycin; local oral
2.5
13.2
105
431
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
2.6
13.2
98
388
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.2
13.2
133
615
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.1
13.1
143
685
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
13.1
161
810
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.4
13.1
110
463
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.3
13.1
47
109
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.6
13.1
314
1970
R05DA01
ATC
ethylmorphine; oral
1.7
13.1
271
1631
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.9
13.1
78
272
1240
FHL
Bronchoscopy
3.2
13.0
67
211
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
7.1
13.0
31
44
SPAT1211
SPAT
Application of soft bandage
1.6
13.0
321
2030
Z94.1
ICD-10 Finland
Heart transplant status
11.0
13.0
24
22
RK520
NOMESCO Finland
NA
6.0
13.0
35
59
C02AC05
ATC
moxonidine; oral
1.9
13.0
195
1060
RS224
NOMESCO Finland
NA
8.8
13.0
27
31
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.9
12.8
31
45
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
3.3
12.8
63
192
SPAT1260
SPAT
Consultation of another employee
1.4
12.8
596
4351
Z08
ICPC
Social welfare problem
3.8
12.8
53
141
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
12.7
576
7613
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.5
12.7
59
172
R05CB02
ATC
bromhexine; systemic
2.8
12.7
79
282
I95.9
ICD-10 Finland
Hypotension, unspecified
3.0
12.7
73
247
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
9.7
12.7
25
26
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.5
12.7
44
99
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.1
12.7
68
221
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
12.6
2137
18899
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
12.6
243
1429
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.7
12.6
573
7574
SPAT1057
SPAT
Peak expiratory flow measurement
2.8
12.6
79
284
J43.0
ICD-10 Finland
MacLeod syndrome
70.1
12.6
14
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.4
12.6
42
1119
D07AA02
ATC
hydrocortisone; topical
1.5
12.5
395
2654
AP1
HP
Catheterization of the left side of the heart
2.5
12.5
94
375
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
12.5
635
4707
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.5
12.4
99
408
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
12.3
1264
10469
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.7
12.3
248
1482
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.6
12.2
54
152
TFP20
NOMESCO Finland
Cardiodefibrillation
1.6
12.1
326
2105
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.8
12.1
75
267
J98.6
ICD-10 Finland
Disorders of diaphragm
6.1
12.1
32
53
4289X
ICD-9 Finland
Heart failure, unspecified
4.5
12.1
42
95
J41.0
ICD-10 Finland
Simple chronic bronchitis
5.3
12.1
36
69
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
11.0
12.0
22
20
H02AB09
ATC
hydrocortisone; systemic
2.7
12.0
81
306
L14
ICPC
Leg/thigh symptom/complaint
1.7
11.9
240
1432
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.9
11.9
166
875
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.7
11.9
252
1528
BC1AD
NOMESCO Finland
CT of adrenal glands
4.3
11.9
43
101
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.9
11.9
172
922
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.2
11.8
43
102
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
3.2
11.8
61
194
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
11.8
196
1103
M48.0
ICD-10 Finland
Spinal stenosis
1.5
11.8
471
3335
XF640
NOMESCO Finland
NA
2.1
11.8
130
626
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
11.7
268
1660
GDC00
NOMESCO Finland
Lobectomy of lung
4.2
11.7
43
103
30041
ICD-8 Finland
Neuroses, Depressiva
3.0
11.7
67
227
A10BX07
ATC
[U] liraglutide; parenteral
3.3
11.6
57
174
ZXE90
NOMESCO Finland
More than 22 hours
3.3
11.6
56
169
196
Kela drug reimbursment
Paricalcitol and cinacalcet
5.3
11.6
34
64
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
5.3
11.6
34
64
0114
NOMESCO Finland
NA
65.1
11.6
13
*
J01DC02
ATC
cefuroxime; systemic
2.0
11.6
153
791
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
6.9
11.6
28
41
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
11.6
106
469
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.4
11.6
54
159
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.5
11.6
91
373
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
22.9
11.6
16
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
11.5
730
5617
ZY000
NOMESCO Finland
Hospital inpatient
4.6
11.5
39
86
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
2.5
11.5
91
374
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
11.5
555
4072
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.6
11.5
50
139
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.7
11.5
77
290
L73.2
ICD-10 Finland
Hidradenitis suppurativa
5.6
11.4
32
57
L04AA01
ATC
[U] ciclosporin; systemic
3.0
11.4
63
210
280
Kela drug reimbursment
Clopidogrel
2.4
11.4
97
416
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.3
11.3
55
167
P76
ICPC
Depressive disorder
2.2
11.3
117
547
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.8
11.3
46
121
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
4.7
11.3
37
79
L04AX01
ATC
azathioprine; systemic
2.1
11.3
127
618
W19
ICD-10 Finland
Unspecified fall
1.6
11.3
320
2096
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.9
11.3
68
240
WX740
NOMESCO Finland
Nitrogen oxide therapy
15.0
11.3
18
12
B01AB10
ATC
tinzaparin; parenteral
1.7
11.3
244
1488
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.6
11.3
286
1822
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.2
11.3
58
184
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.1
11.2
124
598
N02AC04
ATC
dextropropoxyphene; oral
1.8
11.2
178
984
WX320
NOMESCO Finland
Spinalanesthesy
1.3
11.2
788
6160
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
6.5
11.2
28
43
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.2
1071
8765
R24
ICPC
Haemoptysis
4.7
11.2
37
80
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
11.2
402
2782
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.4
11.1
94
399
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.5
11.1
82
326
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.7
11.1
217
1287
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
11.1
368
2501
P29
ICPC
Psychological sympt/compl other
2.2
11.1
108
493
V03AA01
ATC
NA
2.7
11.1
74
278
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
8.0
11.1
24
30
PD5AD
NOMESCO Finland
CT of aorta
2.6
11.0
77
295
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.7
11.0
75
286
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
3.3
11.0
54
166
EBA30
NOMESCO Finland
Excision of root of tooth
1.8
10.9
192
1100
K99
ICPC
Cardiovascular disease other
2.1
10.9
124
607
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.3
10.9
101
450
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
10.9
81
1609
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.9
466
3343
R84
ICPC
Malignant neoplasm bronchus/lung
6.0
10.9
29
49
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.7
10.8
46
126
V03AE01
ATC
polystyrene sulfonate; oral
2.7
10.8
70
259
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
10.8
278
1779
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.4
10.8
87
363
F1246
NOMESCO Finland
NA
10.6
10.7
20
19
J01XX08
ATC
linezolid; systemic
4.6
10.7
36
79
D09AB01
ATC
zinc bandage without supplements; topical
2.6
10.7
79
312
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
10.7
317
2097
5AB14
NOMESCO Finland
NA
9.6
10.7
21
22
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.1
10.7
56
180
V03AE02
ATC
sevelamer; oral
5.4
10.7
31
58
SPAT1251
SPAT
Organisation of medication
1.9
10.7
158
854
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.2
10.7
101
457
162
Kela drug reimbursment
liraglutide
3.5
10.7
48
138
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.8
10.6
43
113
B03XA02
ATC
darbepoetin alfa; parenteral
2.4
10.6
86
360
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
3.7
10.6
45
123
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.5
10.6
114
2036
N04AA02
ATC
biperiden; systemic
2.7
10.6
68
250
C01BD01
ATC
amiodarone; systemic
2.0
10.6
141
732
ZXD35
NOMESCO Finland
Usual procedure
2.0
10.6
128
640
R06.4
ICD-10 Finland
Hyperventilation
3.3
10.6
52
160
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.9
10.6
143
749
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
3.3
10.6
51
155
J94.8
ICD-10 Finland
Other specified pleural conditions
2.4
10.5
83
343
H05AA02
ATC
teriparatide; parenteral
7.0
10.5
25
36
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
10.5
248
1549
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
3.7
10.5
44
119
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
2.8
10.5
64
228
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
10.5
67
245
N03AE01
ATC
clonazepam; systemic
1.8
10.5
183
1044
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
9.2
10.5
21
23
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
9.2
10.5
21
23
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
9.2
10.5
21
23
F31
ICD-10 Finland
Bipolar affective disorder
4.3
10.5
37
86
J01FA01
ATC
erythromycin; systemic
1.5
10.5
317
2113
M10.0
ICD-10 Finland
Idiopathic gout
1.9
10.4
148
789
J92.9
ICD-10 Finland
Pleural plaque without asbestos
2.9
10.4
61
212
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
5.6
10.4
29
52
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
2.1
10.4
116
565
P01
ICPC
Feeling anxious/nervous/tense
1.9
10.4
142
749
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.3
10.4
50
152
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
6.8
10.4
25
37
J01CE08
ATC
benzathine benzylpenicillin; parenteral
3.2
10.3
52
163
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.9
10.3
61
213
J41.8
ICD-10 Finland
Mixed simple and mucopurulent chronic bronchitis
16.1
10.3
16
10
R01AD08
ATC
fluticasone; nasal
1.3
10.3
742
5816
E87.2
ICD-10 Finland
Acidosis
4.5
10.3
35
78
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
32.6
10.3
13
*
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
5.1
10.3
31
61
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
3.6
10.2
44
122
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
5.5
10.2
29
53
J93.8
ICD-10 Finland
Other pneumothorax
5.5
10.2
29
53
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
10.2
639
4899
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.1
10.2
53
170
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.7
10.2
33
70
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
10.2
394
2766
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
3.2
10.2
52
165
S19
ICPC
Skin injury other
1.9
10.1
136
712
R39
ICPC
Respiratory, Physical function test
5.0
10.1
31
62
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
4.2
10.1
37
89
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
7.9
10.1
22
28
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
10.1
56
189
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.7
10.0
42
114
C03AA03
ATC
hydrochlorothiazide; oral
1.5
10.0
388
2725
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.3
10.0
91
405
J02AC03
ATC
voriconazole; systemic
9.1
10.0
20
22
I47.2
ICD-10 Finland
Ventricular tachycardia
2.2
10.0
103
485
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.2
10.0
96
439
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.9
10.0
59
207
SPAT1097
SPAT
Recording of ECG
1.4
10.0
546
4096
OAA67
SPAT
NA
0.2
9.9
14
561
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
3.4
9.9
46
136
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
3.1
9.9
53
174
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
9.8
292
1934
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
9.8
326
2216
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.1
9.8
53
175
318
Kela drug reimbursment
Teriparatide
6.3
9.8
25
40
5198X
ICD-9 Finland
Other diseases of respiratory system, not elsewhere classified
26.1
9.8
13
5
F60.2
ICD-10 Finland
Dissocial personality disorder
26.1
9.8
13
5
I28.9
ICD-10 Finland
Disease of pulmonary vessels, unspecified
26.1
9.8
13
5
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
10.6
9.8
18
17
M01AB51
ATC
indometacin, combinations; oral, rectal
2.2
9.7
101
474
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.6
9.7
270
1762
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
9.5
9.7
19
20
H26.3
ICD-10 Finland
Drug-induced cataract
4.8
9.7
31
65
SPAT1252
SPAT
Overall medication plan or its review
1.6
9.7
274
1791
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.9
9.7
143
775
A10BJ06
ATC
semaglutide; parenteral
2.3
9.7
88
389
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.2
9.7
99
464
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
9.7
362
4953
R03
ICPC
Wheezing
3.3
9.7
47
144
ECB00
NOMESCO Finland
Suture of gingiva
2.0
9.7
119
600
ZXD00
NOMESCO Finland
Emergency procedure
2.0
9.7
122
625
RS121
NOMESCO Finland
NA
4.6
9.7
32
70
N06AA10
ATC
nortriptyline; systemic
2.7
9.7
62
229
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
9.6
82
352
T59.7
ICD-10 Finland
Toxic effect: Carbon dioxide
55.1
9.6
11
*
J69.1
ICD-10 Finland
Pneumonitis due to oils and essences
55.1
9.6
11
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.3
9.6
88
392
T88.8
ICD-10 Finland
Other specified complications of surgical and medical care, not elsewhere classified
5.3
9.6
28
53
N05AN01
ATC
lithium; oral
2.7
9.6
65
246
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.4
9.6
76
315
JN4CD
NOMESCO Finland
Very extensive body CT
1.8
9.6
157
882
WW200
SPAT
NA
0.5
9.6
92
1693
SPAT1281
SPAT
Other administrative function
1.6
9.6
245
1567
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.0
9.6
37
94
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
9.6
651
5057
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
9.6
145
793
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
3.2
9.6
48
151
J01EA01
ATC
trimethoprim; systemic
1.3
9.6
751
5958
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.9
9.5
141
764
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
11.4
9.5
17
15
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.5
9.5
70
280
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
9.5
165
942
J98.2
ICD-10 Finland
Interstitial emphysema
15.0
9.5
15
10
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.0
9.5
36
90
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.5
9.5
69
274
P16
ICPC
Acute alcohol abuse
3.2
9.5
48
152
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
9.4
191
1146
K78
ICPC
Atrial fibrillation/flutter
1.5
9.4
345
2395
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
7.5
9.4
21
28
2AX04
NOMESCO Finland
NA
17.5
9.4
14
8
L03
ICPC
Low back symptom/complaint
1.3
9.4
648
5043
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.1
9.4
101
484
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.5
9.4
72
295
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.6
9.4
31
68
A10BH02
ATC
vildagliptin; oral
2.2
9.4
91
417
D07AB08
ATC
desonide; topical
1.5
9.3
324
2225
K61.0
ICD-10 Finland
Anal abscess
3.3
9.3
45
138
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
6.9
9.3
22
32
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
9.3
77
328
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
8.7
9.3
19
22
L29.9
ICD-10 Finland
Pruritus, unspecified
2.3
9.3
80
348
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
3.0
9.2
53
181
N06AA06
ATC
trimipramine; systemic
2.3
9.2
82
361
N05AX08
ATC
risperidone; systemic
1.5
9.2
289
1942
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
3.7
9.2
38
103
K28
ICPC
Limited function/disability (K)
2.1
9.2
97
461
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
9.2
109
546
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
9.2
1308
11199
N05CD02
ATC
nitrazepam; oral
2.3
9.1
84
374
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.5
9.1
299
2029
S12
ICPC
Insect bite/sting
0.5
9.1
83
1554
F32.8
ICD-10 Finland
Other depressive episodes
3.5
9.1
40
114
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.1
9.1
99
477
M01AX05
ATC
glucosamine; oral
0.7
9.1
435
5729
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
9.1
119
619
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
6.2
9.1
23
37
E000002
ATC
NA
1.5
9.1
292
1974
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
8.3
9.0
19
23
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
5.3
9.0
26
49
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
5.9
9.0
24
41
WX703
NOMESCO Finland
Insertion of pharyngeal or nasopharyngeal tube
15.6
9.0
14
9
P99
ICPC
Psychological disorders other
2.7
9.0
58
215
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
36.8
9.0
11
*
B01AB04
ATC
dalteparin; parenteral
1.7
9.0
178
1059
F17.3
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, withdrawal state
18.6
8.9
13
7
J04AB02
ATC
rifampicin; systemic
2.9
8.9
52
181
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.4
8.9
72
304
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
3.8
8.9
36
96
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.7
8.9
170
1004
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
12.5
8.9
15
12
RS123
NOMESCO Finland
NA
12.5
8.9
15
12
P72
ICPC
Schizophrenia
3.1
8.8
45
144
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
6.8
8.8
21
31
A69.2
ICD-10 Finland
Lyme disease
0.4
8.8
38
910
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.1
8.8
95
458
D07AC13
ATC
mometasone; topical
1.3
8.8
884
7246
RK510
NOMESCO Finland
NA
8.6
8.8
18
21
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.3
8.8
31
73
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
9.5
8.8
17
18
XPX00
NOMESCO Finland
Intraoperative angiography
4.6
8.8
29
64
R52.2
ICD-10 Finland
Other chronic pain
2.1
8.8
94
450
S22.3
ICD-10 Finland
Fracture of rib
1.6
8.7
228
1466
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
3.3
8.7
42
129
F41.00
ICD-10 Finland
Moderate panic disorder
4.4
8.7
30
69
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
3.6
8.7
37
103
NHQ40
NOMESCO Finland
Amputation of toe
2.2
8.7
86
397
A02BA03
ATC
famotidine; systemic
1.7
8.6
163
959
J80
ICD-10 Finland
Adult respiratory distress syndrome
4.5
8.6
29
65
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
8.6
89
421
F2680
NOMESCO Finland
NA
7.6
8.6
19
25
K29.2
ICD-10 Finland
Alcoholic gastritis
7.6
8.6
19
25
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
6.1
8.6
22
36
F20.8
ICD-10 Finland
Other schizophrenia
8.2
8.6
18
22
J20.8
ICD-10 Finland
Acute bronchitis due to other specified organisms
8.2
8.6
18
22
E000006
ATC
NA
1.6
8.5
202
1264
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
4.2
8.5
31
75
R40.2
ICD-10 Finland
Coma, unspecified
3.0
8.5
47
159
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
8.5
88
416
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
6.9
8.5
20
29
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
3.2
8.5
43
137
R03CC03
ATC
terbutaline; systemic
3.6
8.5
36
100
UJF92
NOMESCO Finland
Capsular endoscopy
2.5
8.5
62
247
NH1AD
NOMESCO Finland
Ankle and foot CT
2.5
8.5
62
247
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.9
8.5
49
169
L30.3
ICD-10 Finland
Infective dermatitis
2.0
8.5
108
556
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
2.7
8.5
55
206
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
3.2
8.4
41
127
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.7
8.4
350
4713
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
5.4
8.4
24
45
QBA10
NOMESCO Finland
Incision of skin of trunk
3.1
8.4
44
144
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.1
8.4
94
460
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
8.4
262
1762
SPD01
NOMESCO Finland
Mucosa-supported complete denture
3.4
8.4
38
112
N05AF01
ATC
flupentixol; systemic
2.6
8.3
58
226
C08CA02
ATC
felodipine; oral
1.4
8.3
401
2939
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.4
8.3
65
270
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.0
8.3
104
531
RS223
NOMESCO Finland
NA
10.7
8.3
15
14
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
8.2
366
2644
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.9
8.2
110
576
A06AH03
ATC
naloxegol; oral
2.9
8.2
48
168
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.9
8.2
32
83
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.4
8.2
411
3034
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
8.2
364
2626
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
4.9
8.2
25
51
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.2
8.2
29
69
R01
ICPC
Pain respiratory system
3.0
8.2
44
147
RF120
NOMESCO Finland
NA
3.1
8.2
42
136
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
7.5
8.1
18
24
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.7
8.1
53
199
RK120
NOMESCO Finland
NA
5.1
8.1
24
47
Z49.2
ICD-10 Finland
Other dialysis
3.6
8.1
35
99
81
HP
Angiography of the heart and coronary arteries
1.4
8.1
340
2429
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.8
8.1
32
84
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
4.3
8.1
28
65
N05AD01
ATC
haloperidol; systemic
1.8
8.1
127
706
-50
ICPC
Medication/prescr/renewal
1.7
8.1
151
888
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
3.1
8.1
42
137
S91.0
ICD-10 Finland
Open wound of ankle
3.4
8.1
37
110
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
11.7
8.1
14
12
C07AB02
ATC
metoprolol; systemic
1.3
8.1
908
7540
ZY010
NOMESCO Finland
Hospital outpatient
2.0
8.1
96
482
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
8.0
166
1005
K56.0
ICD-10 Finland
Paralytic ileus
2.7
8.0
53
201
188
Kela drug reimbursment
Psychosis requiring demanding treatment
4.0
8.0
30
75
A10BK01
ATC
dapagliflozin; oral
1.8
8.0
132
744
R51.80
ICD-10 Finland
Headache
1.4
8.0
322
2278
G20
ICD-10 Finland
Parkinson disease
0.4
8.0
39
891
N03AF02
ATC
oxcarbazepine; oral
2.0
8.0
96
484
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
22.0
8.0
11
5
ZXE94
NOMESCO Finland
More than 3 days
22.0
8.0
11
5
R74
ICPC
Upper respiratory infection acute
1.3
8.0
525
4047
RS311
NOMESCO Finland
NA
6.3
8.0
20
32
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.0
8.0
43
144
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
3.2
8.0
39
122
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
8.0
204
1308
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
7.2
7.9
18
25
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.3
7.9
66
284
G72.8
ICD-10 Finland
Other specified myopathies
2.3
7.9
66
284
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
3.6
7.9
33
91
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
7.9
118
646
SPAT1167
SPAT
Insertion of urinary catheter
1.7
7.9
154
914
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
7.9
61
250
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
4.2
7.9
28
67
K23.8
ICD-10 Finland
Disorders of oesophagus in other diseases classified elsewhere
13.0
7.9
13
10
L95.8
ICD-10 Finland
Other vasculitis limited to skin
7.8
7.9
17
22
137
Kela drug reimbursment
Uraemia requiring dialysis
3.0
7.9
42
140
WW500
NOMESCO Finland
Blood transfusion
1.7
7.8
150
885
R05DB05
ATC
pentoxyverine; oral, rectal
1.8
7.8
119
653
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
3.2
7.8
38
118
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
4.0
7.8
29
72
P28
ICPC
Limited function/disability (P)
4.0
7.8
29
72
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.7
7.8
50
184
V03AE03
ATC
lanthanum carbonate; oral
5.1
7.8
23
45
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.5
7.8
58
234
G02BA03
ATC
plastic IUD with progestogen
0.3
7.8
18
563
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
7.8
302
4115
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
2.5
7.8
59
242
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
8.4
7.8
16
19
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
4.3
7.8
27
63
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
7.8
278
1921
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.8
305
2151
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
7.8
530
4110
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
9.4
7.8
15
16
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
4.1
7.8
28
68
SPAT1151
SPAT
Treatment of major wounds
2.6
7.7
54
211
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
4.0
7.7
29
73
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
4.0
7.7
29
73
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.8
7.7
122
680
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
3.9
7.7
30
78
N03AF01
ATC
carbamazepine; oral, rectal
1.6
7.7
184
1159
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.8
7.7
47
171
R52.0
ICD-10 Finland
Acute pain
2.1
7.7
79
372
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.4
7.7
35
104
K02.9
ICD-10 Finland
Dental caries, unspecified
2.6
7.7
51
195
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
1.9
7.7
112
609
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.0
7.7
41
137
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
5.5
7.7
21
38
AA40B
NOMESCO Finland
NA
4.1
7.7
28
69
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
0.5
7.6
72
1329
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
7.6
138
804
R32
ICD-10 Finland
Unspecified urinary incontinence
2.0
7.6
89
446
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.9
7.6
44
153
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.7
7.6
182
2699
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.4
7.6
35
105
R85
ICPC
Malignant neopl respiratory other
8.0
7.6
16
20
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.5
7.6
68
1277
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
4.2
7.6
27
65
3A006
NOMESCO Finland
NA
25.0
7.6
10
*
AA43B
NOMESCO Finland
NA
11.8
7.6
13
11
F2682
NOMESCO Finland
NA
11.8
7.6
13
11
Z72.1
ICD-10 Finland
Alcohol use
2.9
7.6
42
144
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.0
7.6
88
439
T92
ICPC
Gout
2.0
7.5
92
466
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.0
7.5
28
70
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.8
7.5
45
161
PEE23
NOMESCO Finland
Thrombectomy or embolectomy of femoral artery
4.5
7.5
25
56
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.0
7.5
88
440
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.9
7.5
99
519
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
8.8
7.5
15
17
ZXE80
NOMESCO Finland
More than 18 and less than 21 hours
6.2
7.5
19
31
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.8
7.5
30
80
F41.01
ICD-10 Finland
Severe panic disorder
10.0
7.5
14
14
PGH47
NOMESCO Finland
Bypass from femoral to contralateral femoral artery
4.3
7.5
26
61
D02AE01
ATC
carbamide; topical
1.6
7.5
191
1221
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.0
7.5
90
456
B05DA
ATC
Isotonic solutions
3.4
7.5
34
101
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
7.5
70
316
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
7.5
244
1657
Z94.4
ICD-10 Finland
Liver transplant status
7.1
7.5
17
24
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.5
7.5
33
96
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
7.5
785
6457
PD7ZT
NOMESCO Finland
Stent grafting of abdominal aorta
3.5
7.4
32
91
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
3.5
7.4
32
91
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.6
7.4
31
86
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.1
7.4
78
374
JHA00
NOMESCO Finland
Anal or perianal incision
3.0
7.4
39
129
K29.6
ICD-10 Finland
Other gastritis
2.8
7.4
44
157
SBA00
NOMESCO Finland
Microbiological examinations
2.3
7.4
67
299
S20
ICPC
Corn/callosity
2.1
7.4
78
375
PG2YT
NOMESCO Finland
Implantation of arterial endoprothesis not elsewhere classified
6.4
7.4
18
28
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.6
7.4
193
1243
J01DC04
ATC
cefaclor; oral
3.2
7.4
36
113
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
7.6
7.4
16
21
M10.2
ICD-10 Finland
Drug-induced gout
6.0
7.4
19
32
TNX30
NOMESCO Finland
Soft bandage, unspecified region
2.8
7.4
44
158
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
5.6
7.4
20
36
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
7.3
483
3723
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.9
7.3
107
581
H05BX01
ATC
cinacalcet; oral
3.7
7.3
30
82
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.7
7.3
48
182
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.8
7.3
111
612
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
3.3
7.3
34
103
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
4.3
7.3
25
58
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
8.4
7.3
15
18
J01AA07
ATC
tetracycline; systemic
1.4
7.3
326
2355
G04CA02
ATC
tamsulosin; oral
1.2
7.3
1265
10998
GD1LA
NOMESCO Finland
GD
2.3
7.3
62
271
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.4
7.3
33
98
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.4
7.3
33
98
P80
ICPC
Personality disorder
6.8
7.3
17
25
5AH02
NOMESCO Finland
NA
9.4
7.3
14
15
S72.0
ICD-10 Finland
Fracture of neck of femur
1.6
7.3
165
1027
R07.3
ICD-10 Finland
Other chest pain
1.5
7.3
280
1966
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
7.3
322
4293
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.3
1411
12406
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.7
7.3
145
872
D05AX52
ATC
calcipotriol, combinations; topical
1.6
7.2
160
989
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.4
7.2
34
787
P06
ICPC
Sleep disturbance
1.5
7.2
225
1511
E9609
ICD-8 Finland
Fight, brawl, rape
3.9
7.2
28
73
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.4
7.2
20
37
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.0
7.2
39
132
A99
ICPC
Disease/condition unspecnature/site
1.5
7.2
242
1657
F32
ICD-10 Finland
Depressive episode
1.9
7.1
94
494
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
7.1
133
780
RK122
NOMESCO Finland
NA
30.0
7.1
9
*
PDQ20
NOMESCO Finland
Insertion of endovascular graft into common iliac artery
3.7
7.1
29
79
A10BJ05
ATC
dulaglutide; parenteral
3.7
7.1
29
79
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
20.0
7.1
10
5
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.1
7.1
73
346
D19
ICPC
Teeth/gum symptom/complaint
0.7
7.1
375
4874
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.9
7.1
15
19
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.3
7.1
63
281
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.9
7.1
93
487
F10.24
ICD-10 Finland
Alcohol depence active use
2.9
7.1
41
143
A10AB06
ATC
insulin glulisine; parenteral
2.9
7.1
41
143
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
2.4
7.1
56
233
ECB20
NOMESCO Finland
Oral alveoplasty
3.0
7.1
38
128
I70.0
ICD-10 Finland
Atherosclerosis of aorta
3.2
7.1
34
106
B05DB
ATC
Hypertonic solutions
3.5
7.0
30
85
N06AA04
ATC
clomipramine; systemic
2.4
7.0
54
224
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.6
7.0
29
80
J01MA11
ATC
grepafloxacin; oral
10.0
7.0
13
13
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
10.0
7.0
13
13
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.6
7.0
154
949
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.0
7.0
90
466
I95.8
ICD-10 Finland
Other hypotension
4.7
7.0
22
47
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.5
7.0
52
1032
S18
ICPC
Laceration/cut
1.2
7.0
1396
12296
AP2
HP
Catheterization of the right side of the heart
4.1
7.0
25
61
SPA47
NOMESCO Finland
Precision impression for denture
2.3
7.0
57
245
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
7.0
703
5750
Y4301
ICD-8 Finland
Preventive sterilization, Legal sterilization, medico-social reasons (weakness)
3.1
6.9
35
113
U05
ICPC
Urination problems other
1.6
6.9
165
1041
S02.51
ICD-10 Finland
Fracture of tooth, open
0.6
6.9
103
1690
C09CA01
ATC
losartan; oral
1.2
6.9
834
6967
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
2.5
6.9
52
213
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
3.1
6.9
35
114
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
4.0
6.9
25
62
S06
ICPC
Rash localized
1.6
6.9
169
1076
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.8
6.9
109
611
I21.10
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
2.4
6.9
52
214
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
3.7
6.8
28
77
5BA08
NOMESCO Finland
NA
3.7
6.8
28
77
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.8
132
784
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.8
6.8
21
44
SPAT1310
SPAT
Counselling related to known health issue
1.2
6.8
968
8231
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.5
6.8
49
197
C08CA05
ATC
nifedipine; systemic
1.4
6.8
267
1882
N05CF02
ATC
zolpidem; oral
1.3
6.8
440
3388
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.2
6.8
63
286
PD4AD
NOMESCO Finland
CT of lower extremity arteries
4.2
6.8
24
58
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.4
6.8
55
235
H05BX02
ATC
paricalcitol; systemic
9.3
6.8
13
14
G03AC03
ATC
levonorgestrel; systemic
0.5
6.8
54
1044
N06DA04
ATC
galantamine; oral
0.4
6.8
22
587
B37.8
ICD-10 Finland
Candidiasis of other sites
6.1
6.8
17
28
R50
ICPC
Respiratory, Medication/prescr/renewal
6.1
6.8
17
28
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
5.3
6.8
19
36
Z94.3
ICD-10 Finland
Heart and lungs transplant status
40.1
6.8
8
*
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
40.1
6.8
8
*
N25.0
ICD-10 Finland
Renal osteodystrophy
5.6
6.7
18
32
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
5.6
6.7
18
32
1370X
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,MUU JÄLKITILA]
16.7
6.7
10
6
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
16.7
6.7
10
6
J34.2
ICD-10 Finland
Deviated nasal septum
1.7
6.7
140
853
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
6.7
516
4068
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
2.7
6.7
44
167
J12.8
ICD-10 Finland
Other viral pneumonia
3.3
6.7
31
94
F22.0
ICD-10 Finland
Delusional disorder
2.5
6.7
49
199
N81.1
ICD-10 Finland
Cystocele
0.5
6.7
43
890
R4120
NOMESCO Finland
Occupational therapy
1.6
6.7
178
1152
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
6.7
226
1548
N06AX05
ATC
trazodone; oral
2.2
6.7
63
290
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.9
6.7
86
450
A10BK03
ATC
empagliflozin; oral
1.5
6.7
208
1401
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
3.3
6.6
31
95
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
6.6
421
3231
PD1AE
NOMESCO Finland
Ultrasound examination of abdominal aortta
2.7
6.6
43
162
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
6.6
219
1492
I46.9
ICD-10 Finland
Cardiac arrest, unspecified
3.3
6.6
30
90
L95
ICPC
Osteoporosis
2.0
6.6
83
429
L16
ICPC
Ankle symptom/complaint
1.5
6.6
252
1770
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.1
6.6
65
305
SPAT1325
SPAT
Vaccination
1.2
6.6
1229
10738
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
4.2
6.6
23
55
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.2
6.6
32
101
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
3.4
6.6
29
85
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
2.5
6.6
48
195
ZXE92
NOMESCO Finland
2-3 days
12.2
6.6
11
9
ZX122
NOMESCO Finland
Intra-arterial
4.0
6.6
24
60
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.0
6.6
24
60
Z94.7
ICD-10 Finland
Corneal transplant status
4.0
6.6
24
60
321
Kela drug reimbursment
Paricalcitol and cinacalcet
3.6
6.6
27
75
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
3.1
6.6
33
107
R43
ICPC
Respiratory, Other diagnostic procedure
3.7
6.5
26
70
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
6.5
131
788
SPAT1081
SPAT
Cardiorespiratory global assessment
1.5
6.5
199
1331
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.5
6.5
47
189
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.5
76
382
OAB48
SPAT
NA
0.4
6.5
19
531
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
6.5
299
2172
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
1.9
6.5
86
451
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.9
6.5
94
509
SPAT1342
SPAT
Referral to specialised care
2.6
6.5
44
172
SPAT1360
SPAT
Extensive global examination
1.4
6.5
252
1778
M70.2
ICD-10 Finland
Olecranon bursitis
1.7
6.5
118
689
F20.5
ICD-10 Finland
Residual schizophrenia
3.9
6.5
24
61
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
6.5
257
1819
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
6.5
467
3654
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
3.7
6.5
26
71
DQA10
NOMESCO Finland
Biopsy of larynx
3.8
6.5
25
66
42600
ICD-8 Finland
Pulmonary heart disease, Cor pulmonale
69.9
6.4
7
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.5
6.4
205
1387
R35
ICD-10 Finland
Polyuria
1.5
6.4
231
1603
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
3.0
6.4
33
109
P70
ICPC
Dementia
0.4
6.4
19
526
ZX100
NOMESCO Finland
Oral
2.2
6.4
58
262
4040
NOMESCO Finland
NA
14.3
6.4
10
7
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
6.4
159
1016
SPAT1139
SPAT
Nutrition survey
1.8
6.4
105
598
SPAT1244
SPAT
Occupational therapy
2.6
6.4
42
161
I72.4
ICD-10 Finland
Aneurysm and dissection of artery of lower extremity
3.1
6.4
32
104
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
6.4
267
1912
GAC00
NOMESCO Finland
Biopsy of pleura
3.6
6.4
26
72
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
3.6
6.4
26
72
116
Kela drug reimbursment
Prostate cancer
0.7
6.4
175
2525
A29
ICPC
General symptom/complaint other
1.4
6.4
351
2634
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.6
6.3
162
1043
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.8
6.3
95
524
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
6.3
67
1198
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
2.7
6.3
39
145
PEC23
NOMESCO Finland
Suture of common femoral artery
4.2
6.3
22
53
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
6.3
155
989
J94.1
ICD-10 Finland
Fibrothorax
9.3
6.3
12
13
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.9
6.3
36
125
X84
ICD-10 Finland
Intentional self-harm by unspecified means
18.0
6.3
9
5
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.2
6.3
60
279
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
6.2
173
1133
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.3
6.2
29
89
A08AB01
ATC
orlistat; oral
3.1
6.2
31
100
A02BX05
ATC
bismuth subcitrate; oral
2.1
6.2
64
304
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
26.7
6.2
8
*
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
26.7
6.2
8
*
F13.9
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder
26.7
6.2
8
*
AB35W
NOMESCO Finland
NA
26.7
6.2
8
*
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.6
6.2
42
164
HAMTE
NOMESCO Finland
NA
3.3
6.2
28
84
A10BG03
ATC
pioglitazone; oral
1.9
6.2
88
476
R06
ICD-10 Finland
Abnormalities of breathing
3.2
6.2
30
95
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.6
6.2
168
1098
N06AB05
ATC
paroxetine; oral
1.6
6.2
139
863
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.6
6.2
41
158
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
6.2
45
183
D91
ICPC
Abdominal hernia other
2.6
6.2
42
165
U14
ICPC
Kidney symptom/complaint
2.2
6.2
57
261
F20
ICD-10 Finland
Schizophrenia
5.0
6.2
18
36
30088
ICD-8 Finland
Neuroses, Other
3.9
6.2
23
59
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.1
6.2
31
101
WX213
NOMESCO Finland
Lower leg blockade
3.1
6.2
31
101
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
3.1
6.2
31
101
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
3.8
6.2
24
64
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
3.8
6.2
24
64
SPAT1227
SPAT
Substance abuse rehabilitation
4.5
6.1
20
45
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.7
6.1
110
643
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.1
6.1
30
96
ZPB24
NOMESCO Finland
Patch of vein
7.7
6.1
13
17
-56
ICPC
Dressing/pressure/compress/tamponade
2.2
6.1
58
266
SPE01
NOMESCO Finland
Mucosa-supported partial denture
2.3
6.1
53
235
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
12.5
6.1
10
8
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
12.5
6.1
10
8
FXG00
NOMESCO Finland
Insertion and use of IABP
4.0
6.1
22
55
PEN25
NOMESCO Finland
Plastic repair of superficial femoral artery
4.0
6.1
22
55
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
6.1
125
761
B37.08
ICD-10 Finland
Other candidal stomatitis
3.7
6.1
24
65
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
3.7
6.1
24
65
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
6.1
87
474
N04BD01
ATC
selegiline; oral
0.2
6.1
8
329
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
8.6
6.0
12
14
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
2.4
6.0
48
205
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.9
6.0
18
37
QWC00
NOMESCO Finland
Reoperation for superficial infection in surgery of skin
4.9
6.0
18
37
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.9
6.0
18
37
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
10.0
6.0
11
11
XX4AW
NOMESCO Finland
NA
10.0
6.0
11
11
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
6.7
6.0
14
21
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
6.7
6.0
14
21
RD112
NOMESCO Finland
NA
6.7
6.0
14
21
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
1.6
6.0
158
1021
K86.1
ICD-10 Finland
Other chronic pancreatitis
2.8
6.0
36
131
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
2414
11995
3.10
310.44
7.3
4.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
396
440
9.74
307.65
3.2
2.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1835
4828
5.62
307.65
10.4
6.6
kpa
5.7
5.0
80.40
1737
4574
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1090
2170
6.25
307.65
9.7
8.6
mmol/l
25.7
24.1
35.12
1001
1998
(3003396) Base excess in Arterial blood by calculation
1828
4807
5.61
307.65
10.4
6.6
mmol/l
2.8
0.8
57.97
1578
3674
(3016502) Oxygen saturation in Arterial blood
1545
4379
4.78
307.65
10.4
6.9
%
92.2
95.6
53.93
1476
4208
(3022313) Gas panel - Capillary blood
927
1836
6.05
307.65
8.9
3.5
—
—
—
0
0
(3009343) pH of Capillary blood
1162
2556
5.72
307.65
8.7
3.4
ph
7.4
7.4
0.43
127
309
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1808
6912
3.64
307.65
3.1
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
740
1600
5.31
307.65
9.7
3.8
mmol/l
26.2
24.6
27.06
718
1441
(3027801) Oxygen [Partial pressure] in Arterial blood
1834
4827
5.61
307.65
10.4
6.5
kpa
9.2
12.2
168.89
1731
4570
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1147
2472
5.83
307.65
8.3
3.4
mmol/l
3.3
1.6
34.63
1000
1750
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1166
2595
5.66
307.65
8.8
3.4
kpa
5.7
5.1
56.75
1131
2369
(3019060) Gas panel - Arterial blood
1550
2749
7.95
307.65
6.1
4.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
482
852
6.19
264.05
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
482
852
6.19
264.05
1.9
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1264
4756
3.27
255.28
3.0
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1133
4015
3.41
252.12
12.9
7.3
g/l
125.8
119.8
15.19
1103
3867
(4010399)
793
2220
4.10
250.78
1.8
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1249
4736
3.24
248.21
3.0
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
620
1465
4.73
244.45
4.0
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
799
2302
3.98
242.28
15.0
9.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
491
1059
5.06
215.22
6.6
2.7
mmol/l
26.9
24.4
18.34
453
914
(42870588) Differential panel, method unspecified - Blood
2247
12353
2.58
214.11
8.0
5.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1052
4008
3.10
203.13
4.7
3.0
ng/l
331.1
252.3
3.65
997
3667
(3028626) Oxygen [Partial pressure] in Capillary blood
432
895
5.22
198.00
6.0
2.5
kpa
7.3
7.9
11.49
414
826
(3020779) Urea [Moles/volume] in Serum or Plasma
1032
3995
3.03
192.81
11.3
6.9
mmol/l
12.0
11.4
1.23
970
3758
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1395
6369
2.70
190.68
5.7
3.0
mmol/l
0.8
0.8
6.42
1291
5896
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1252
5416
2.79
190.16
8.5
5.8
mmol/l
1.1
1.0
9.37
1145
4968
(3047181) Lactate [Moles/volume] in Blood
511
1267
4.41
187.87
11.6
5.8
mmol/l
1.2
1.3
2.38
477
1114
(3022096) Basophils/100 leukocytes in Blood
2593
15972
2.40
183.07
8.7
5.8
%
0.5
0.6
40.89
2473
14690
(3008152) Bicarbonate [Moles/volume] in Arterial blood
788
2692
3.32
181.34
12.4
6.3
mmol/l
26.8
24.2
43.58
757
2508
(3000492) Spirometry study
739
2448
3.40
178.59
2.2
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2628
16421
2.37
177.55
8.8
5.7
%
2.3
2.9
33.61
2511
15084
(3019069) Monocytes/100 leukocytes in Blood
2631
16495
2.36
175.69
9.2
6.1
%
8.6
9.0
6.90
2514
15205
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
412
917
4.83
173.04
2.3
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
412
929
4.77
170.27
10.9
6.6
mmol/l
103.8
105.3
6.55
389
826
(3039000) Anion gap in Blood
412
929
4.77
170.27
10.9
6.6
mmol/l
10.4
11.3
5.35
389
826
(3012544) pH of Venous blood
1014
4161
2.84
168.06
6.1
3.6
ph
7.4
7.4
—
9
23
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
626
1940
3.57
167.36
6.0
3.7
mmol/l
25.4
23.9
15.33
593
1715
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
396
878
4.84
166.97
2.4
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2636
16777
2.31
166.56
9.0
5.9
%
20.1
26.1
152.29
2502
15348
(3024891) Influenza virus A+B Ag [Presence] in Specimen
359
742
5.16
164.39
1.6
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
265
411
6.78
163.92
4.2
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2585
16502
2.27
159.62
8.8
5.7
%
64.7
58.4
126.63
2465
15184
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2226
13369
2.27
159.45
5.3
3.1
ng/l
2560.5
1905.9
5.18
2016
11595
(3002032) Base excess in Venous blood by calculation
964
3982
2.79
156.76
6.2
3.6
mmol/l
3.8
1.7
29.93
806
3161
(3021447) Carbon dioxide [Partial pressure] in Venous blood
960
4002
2.76
153.04
6.2
3.6
kpa
6.6
5.8
54.89
908
3854
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
676
2325
3.23
152.31
13.6
6.7
mmol/l
27.3
24.6
33.51
666
2307
(3021901) Oxygen saturation in Capillary blood
353
772
4.86
151.03
5.6
2.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
320
651
5.20
148.98
2.2
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
88
20
44.83
148.63
1.9
1.5
umol/l
45.0
57.6
0.67
88
20
(3000991) Gas panel - Venous blood
860
3512
2.78
141.75
14.0
7.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1159
5496
2.48
140.48
2.9
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2686
18036
2.15
138.17
8.9
5.6
e9/l
0.2
0.2
2.06
2463
15489
(1616796) Gas panel - Central venous blood
369
909
4.32
135.73
8.6
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
518
1626
3.46
134.58
3.5
2.8
u/ml
0.3
0.3
0.92
307
909
(3001604) Monocytes [#/volume] in Blood
2598
17416
2.11
131.76
8.4
5.4
e9/l
0.7
0.6
61.28
2358
14724
(3006315) Basophils [#/volume] in Blood
2609
17533
2.11
131.25
8.3
5.4
e9/l
0.0
0.0
0.70
2371
14847
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
537
1818
3.21
123.02
9.3
4.8
%
2.2
1.6
15.05
512
1703
(3019198) Lymphocytes [#/volume] in Blood
2611
17817
2.06
122.75
8.5
5.5
e9/l
1.7
1.9
6.46
2387
15324
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1351
7237
2.22
120.75
2.5
1.7
mg/l
1.5
1.6
0.35
1099
5650
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
721
2908
2.75
120.33
1.9
1.6
—
—
—
0
0
(44790047)
222
403
5.73
116.88
2.6
1.3
—
—
—
0
0
(44806118)
222
403
5.73
116.88
2.6
1.3
—
—
—
0
0
(44790048)
222
403
5.73
116.88
2.6
1.3
—
—
—
0
0
(44790049)
222
403
5.73
116.88
2.6
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2588
17848
2.01
115.20
13.0
6.1
mmol/l
1.2
1.2
23.81
2376
15974
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1442
8063
2.14
114.57
7.1
4.0
ng/l
547.2
540.7
0.01
1310
6935
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
242
485
5.21
114.26
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
341
901
4.00
113.75
2.3
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
336
902
3.94
109.55
12.2
4.5
kpa
7.7
8.4
12.86
327
882
(3007930) Methemoglobin/Hemoglobin.total in Blood
508
1784
3.07
108.82
9.8
4.9
%
0.9
0.9
1.84
484
1673
(3019977) pH of Arterial blood
156
213
7.54
108.11
2.9
2.3
ph
7.4
7.4
0.36
92
73
(3042631) Mycobacterium sp identified in Specimen
257
568
4.73
108.07
3.4
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
282
672
4.40
107.91
2.5
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
247
531
4.86
107.39
2.3
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
827
3761
2.46
106.86
13.1
6.2
mmol/l
1.3
1.4
0.96
769
3597
(4015189)
107
90
12.14
106.52
2.8
2.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
330
899
3.87
105.32
12.3
4.5
kpa
5.7
4.9
28.65
321
880
(3012501) Base excess in Blood by calculation
329
899
3.86
104.53
12.3
4.5
mmol/l
4.3
2.5
14.90
295
586
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
440
1463
3.22
103.27
3.4
2.2
ug/l
409.2
787.8
1.35
421
1387
(3032080) INR in Blood by Coagulation assay
2487
17334
1.93
102.65
17.0
11.1
inr
1.4
1.4
0.06
590
4706
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
254
589
4.50
100.55
1.7
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1090
5746
2.17
98.56
3.7
2.6
%
17.8
22.5
23.13
868
4831
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
212
433
5.08
97.82
2.8
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
494
1810
2.93
97.76
2.9
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2433
17064
1.89
96.09
8.1
4.8
g/l
32.0
34.6
87.11
2276
15703
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2708
19696
1.89
95.06
8.7
6.2
umol/l
11.7
12.7
2.61
2603
18629
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1120
6094
2.10
92.52
3.6
2.6
g/l
2.3
2.2
4.17
1032
5595
(3022948) Iron [Moles/volume] in Serum or Plasma
1179
6551
2.07
91.99
3.6
2.6
umol/l
10.2
12.5
22.10
1093
6020
(3010421) pH of Blood
341
1041
3.46
91.61
12.5
4.3
ph
7.4
7.4
1.45
320
882
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
459
1678
2.92
90.98
2.6
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
872
4343
2.24
89.98
2.3
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
139
205
6.96
89.82
2.6
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
223
520
4.45
87.56
1.6
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1682
10724
1.89
87.02
5.1
3.2
u/l
34.8
38.4
0.64
1588
10094
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
162
293
5.69
85.48
3.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
67
36
18.87
84.84
3.6
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
304
906
3.52
84.66
3.7
2.1
g/l
132.5
127.7
1.97
207
660
(3042733) HLA Ab [Presence] in Serum
88
78
11.48
84.65
5.2
4.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
606
2645
2.48
84.29
2.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
222
538
4.28
82.90
2.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
152
268
5.83
82.38
1.3
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2647
19683
1.80
80.54
14.2
6.9
mmol/l
1.2
1.2
31.88
2290
16448
(3013650) Neutrophils [#/volume] in Blood by Automated count
2717
20374
1.80
80.20
12.1
8.5
e9/l
5.6
4.3
98.99
2481
17556
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
817
4149
2.17
79.44
2.9
2.8
umol/l
9.1
9.8
0.28
705
3662
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
567
2474
2.47
78.64
2.0
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
287
865
3.47
78.47
2.4
2.6
umol/l
32.4
35.0
0.86
247
709
(3005322) IgE [Units/volume] in Serum or Plasma
396
1452
2.89
77.71
1.6
1.3
u/ml
298.4
248.2
0.60
374
1322
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
737
3632
2.22
77.06
2.2
2.2
g/l
0.2
0.2
1.14
678
3348
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
473
1914
2.64
76.73
2.5
1.8
ug/l
1.8
2.5
0.65
405
1652
(3024928) Oxygen saturation in Venous blood
287
890
3.37
74.98
4.6
2.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
792
4058
2.15
74.90
2.5
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
686
3328
2.24
74.35
5.7
3.0
kpa
4.8
4.5
2.13
637
3195
(3037692) Legionella sp identified in Specimen by Organism specific culture
99
126
8.01
72.80
2.7
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
104
141
7.52
72.45
40.8
23.5
ug/l
144.0
113.9
2.85
82
116
(3026250) Tacrolimus [Mass/volume] in Blood
94
113
8.47
72.44
35.3
31.2
ug/l
8.0
7.3
1.32
82
100
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
118
188
6.41
70.83
3.8
3.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
674
3328
2.20
69.64
1.9
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1726
11734
1.75
67.99
3.6
2.5
u/l
53.5
59.5
5.98
1602
10782
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
231
680
3.52
65.37
16.6
4.6
iu/ml
398.9
4361.5
0.81
65
95
(3014576) Chloride [Moles/volume] in Serum or Plasma
936
5359
1.93
64.10
14.3
6.4
mmol/l
102.7
104.5
20.32
900
5238
(3001964) Herpes simplex virus Ag [Presence] in Specimen
76
82
9.41
63.68
2.8
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
1285
8181
1.79
62.50
4.1
2.9
mosm/kgh2o
517.9
564.7
15.31
1135
6964
(3013826) Glucose [Moles/volume] in Serum or Plasma
2864
22635
1.69
62.24
12.1
4.8
mmol/l
7.1
6.9
5.49
2748
21329
(40767503) Oxygen content in Capillary blood by calculation
266
888
3.12
61.39
5.2
2.4
%
16.2
16.1
0.12
169
448
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
199
561
3.66
60.08
7.7
6.4
mg/l
11.6
12.3
0.98
175
510
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
892
5126
1.92
59.98
3.1
4.1
u/l
244.0
247.6
0.38
833
4812
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2110
15611
1.64
57.58
7.3
4.1
ng/l
93.1
103.6
0.08
1742
12147
(3026008) Bacteria identified in Urine by Culture
1682
11773
1.67
56.90
4.2
3.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
275
978
2.93
56.74
3.1
2.3
g/l
3.9
3.6
2.06
258
929
(3027456) Digoxin [Moles/volume] in Serum or Plasma
280
1011
2.88
56.18
3.6
3.0
nmol/l
0.9
0.8
0.92
235
754
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
542
2684
2.15
54.85
16.2
8.1
%
0.5
0.7
14.62
535
2661
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
187
541
3.56
54.29
6.2
2.2
u/ml
585.2
2236.7
0.89
12
46
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
536
2689
2.12
52.33
16.3
8.0
%
1.7
1.3
10.16
529
2669
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
321
1294
2.59
51.96
1.4
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
69
87
8.04
51.13
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2936
34201
0.62
50.73
5.7
5.4
mmol/l
2.3
2.6
57.50
2568
30745
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1030
6486
1.75
50.37
3.1
2.0
s
30.7
30.2
1.68
999
6285
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1514
10569
1.64
50.27
2.8
2.3
mg/l
3.8
3.0
16.72
1289
8851
(3036481) Cortisol [Moles/volume] in Serum or Plasma
554
2860
2.06
50.01
2.2
2.3
nmol/l
321.6
376.8
7.36
499
2599
(3005719) IgG [Mass/volume] in Serum or Plasma
498
2480
2.13
49.44
3.1
2.7
g/l
9.9
10.7
4.36
458
2245
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
256
949
2.80
48.84
3.3
2.1
%
88.3
86.9
0.43
244
904
(3028026) IgM [Mass/volume] in Serum or Plasma
420
1965
2.25
48.73
2.1
1.9
g/l
1.2
1.4
1.56
379
1752
(3009445) Proteinase 3 Ab [Units/volume] in Serum
367
1623
2.37
48.58
1.2
1.6
u/ml
3.8
18.0
—
5
43
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2844
33269
0.63
48.47
5.2
4.8
mmol/l
4.1
4.4
33.46
2523
30080
(3024471) HLA-A [Type]
68
91
7.57
47.91
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2814
32918
0.63
46.82
5.2
4.7
mmol/l
1.3
1.4
21.27
2456
29511
(3028271) Lactate [Moles/volume] in Capillary blood
198
652
3.13
46.69
3.4
1.9
mmol/l
1.6
1.8
1.26
191
636
(40757373) Influenza virus identified in Isolate
68
94
7.33
46.57
2.6
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
293
1197
2.54
46.05
6.5
3.5
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
85
151
5.72
45.71
8.7
7.0
mmol/l
27.2
24.7
3.99
79
134
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
539
2868
1.99
44.48
2.0
1.7
%
1.8
1.6
5.32
447
2374
(1761868) Lipid panel - Serum or Plasma
577
9805
0.53
43.82
3.5
3.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
134
362
3.78
43.05
2.3
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
233
880
2.73
42.85
3.5
2.4
%
217.0
202.9
1.52
223
840
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
137
381
3.67
42.20
2.2
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
142
413
3.51
40.90
1.1
1.1
g/l
1.6
1.6
0.56
126
373
(3033658) Prothrombin time (PT) actual/Normal
1334
9413
1.58
40.53
7.7
4.0
%
80.7
82.9
2.17
1295
9192
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
275
1159
2.46
40.39
1.7
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
550
3046
1.91
40.16
5.8
3.9
ng/l
132.4
100.2
7.04
460
2593
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
95
210
4.60
39.86
3.2
1.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
253
1032
2.53
39.83
1.3
1.4
iu/ml
7.3
13.6
—
5
20
(3027945) Reticulocytes/100 erythrocytes in Blood
852
5401
1.71
39.56
2.5
2.4
%
1.9
1.7
8.98
731
4697
(3003434) Protein [Mass/volume] in Pleural fluid
196
714
2.82
38.60
1.4
1.5
g/l
31.1
30.9
0.08
169
632
(3019309) Folate [Moles/volume] in Red Blood Cells
1257
8838
1.58
38.40
2.0
1.8
nmol/l
1003.5
1166.2
7.52
914
6566
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2753
31886
0.67
37.71
4.8
4.3
mmol/l
1.5
1.3
28.03
2383
28333
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
119
328
3.70
37.16
2.0
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
162
549
3.02
36.37
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2954
33650
0.67
36.05
5.9
5.1
mmol/l
6.4
6.1
12.60
2567
29916
(3018418) pH of Serum or Plasma
1560
11647
1.51
35.70
6.9
4.1
ph
7.4
7.4
0.09
308
2188
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
97
241
4.09
35.05
1.1
1.2
—
—
—
0
0
(4306422)
124
366
3.45
34.95
1.3
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
174
628
2.84
34.87
1.4
1.5
e6/l
3956.5
1749.4
0.57
134
447
(3051651) Icteric interference index of Serum or Plasma
96
238
4.10
34.79
7.1
3.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
185
695
2.73
34.37
1.5
1.3
mmol/l
54.6
63.2
1.90
140
559
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
85
194
4.44
34.31
1.8
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
85
194
4.44
34.31
1.8
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
85
194
4.44
34.31
1.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
85
194
4.44
34.31
1.8
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
495
2791
1.87
33.93
2.1
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
49
67
7.38
33.89
1.8
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
78
169
4.68
33.58
1.5
1.3
u/ml
1.9
1.1
0.41
63
83
(3022217) INR in Platelet poor plasma by Coagulation assay
953
6453
1.60
33.51
34.0
30.3
inr
1.6
1.5
1.56
97
892
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
52
77
6.82
33.49
7.7
1.8
—
—
—
0
0
(3020891) Body temperature
342
1706
2.08
33.42
7.9
4.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
133
422
3.21
33.40
2.9
3.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
97
250
3.94
33.35
2.1
2.3
—
—
—
0
0
(3036489) Thrombin time
272
1241
2.27
33.29
3.2
1.9
s
21.7
21.6
0.02
249
1126
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1149
15548
0.65
32.84
3.9
4.7
%
21.1
22.3
1.44
471
8323
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
420
2270
1.93
32.73
1.6
1.7
g/l
1.7
1.5
3.52
366
1922
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
273
1267
2.23
32.06
1.6
1.5
titre
103.1
276.3
1.65
13
59
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
118
357
3.37
32.01
1.3
1.1
%
110.8
111.0
0.02
109
318
(40758558) Short blood count panel - Blood
1230
8931
1.51
31.32
9.8
6.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
110
323
3.46
31.28
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
110
323
3.46
31.28
1.7
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
110
323
3.46
31.28
1.7
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
71
151
4.76
31.27
2.0
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
88
222
4.02
31.18
1.6
1.2
promille
1.1
1.1
0.13
76
175
(3028308) Erythrocytes [#/volume] in Pleural fluid
157
570
2.82
31.14
1.4
1.4
e6/l
82499.3
81692.0
0.01
95
332
(3000963) Hemoglobin [Mass/volume] in Blood
3393
37341
0.67
31.13
58.7
25.1
g/l
130.0
133.8
28.97
3315
36589
(3010813) Leukocytes [#/volume] in Blood
3394
37343
0.67
30.99
58.2
25.0
e9/l
8.5
6.9
187.69
3292
35985
(3026361) Erythrocytes [#/volume] in Blood
3393
37334
0.67
30.99
58.1
24.9
e12/l
4.4
4.4
2.14
3291
35977
(3024731) MCV [Entitic volume]
3393
37333
0.67
30.97
57.9
24.9
fl
92.2
91.8
3.90
3317
36576
(3035941) MCH [Entitic mass]
3393
37332
0.67
30.95
57.9
24.8
pg
30.1
30.5
29.62
3316
36574
(3007461) Platelets [#/volume] in Blood
3393
37328
0.67
30.87
58.2
25.0
e9/l
253.5
235.5
36.31
3306
36125
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
152
545
2.85
30.86
1.6
1.9
ug/l
24.3
26.3
0.15
145
530
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
70
149
4.75
30.80
1.9
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
70
149
4.75
30.80
1.9
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1381
10334
1.48
30.09
4.8
2.9
umol/l
4367.7
5992.0
0.65
1185
8737
(3020630) Protein [Mass/volume] in Serum or Plasma
616
3829
1.70
30.09
2.1
2.6
g/l
64.2
66.1
7.27
543
3413
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
500
2930
1.79
30.08
2.1
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
60
116
5.23
29.51
2.3
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1576
12134
1.45
29.49
3.3
2.2
u/l
275.0
218.4
0.56
1476
11306
(3000850) Epithelial cells [#/volume] in Urine
1195
8716
1.50
29.46
4.0
2.7
e6/l
4.9
4.1
1.98
1060
7625
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
761
11044
0.63
29.24
2.7
3.3
ug/l
0.8
0.8
0.40
491
7955
(4198724)
35
38
9.27
29.14
2.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
150
552
2.77
29.01
1.5
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
143
513
2.84
29.01
2.0
1.4
u/ml
122.9
125.9
0.09
27
107
(3004119) Hemoglobin [Mass/volume] in Venous blood
460
2679
1.80
28.18
6.4
3.2
g/l
126.5
127.4
0.34
436
2609
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
662
4271
1.64
27.89
5.9
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1789
14209
1.42
27.79
4.0
2.8
ug/l
161.6
168.1
0.24
1620
12785
(3014148) Varicella zoster virus Ab [Titer] in Serum
86
232
3.76
27.77
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
154
595
2.64
27.11
1.8
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
42
63
6.72
26.74
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3298
36249
0.69
26.62
18.0
11.1
u/l
25.8
25.9
0.07
3197
34572
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2863
32242
0.71
26.59
37.4
16.2
ml/min/173m2
71.0
72.8
3.40
2507
26785
(3028192) IgG subclass 2 [Mass/volume] in Serum
90
259
3.52
26.44
1.4
1.3
g/l
2.1
3.1
5.84
66
183
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
43
67
6.47
26.42
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
184
784
2.40
26.37
1.8
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
112
371
3.07
26.22
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
84
233
3.65
26.07
1.9
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
123
432
2.90
25.97
1.4
1.6
g/l
0.6
0.9
2.72
91
329
(3019225) pH of Specimen
634
4116
1.63
25.93
5.7
4.7
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
89
259
3.48
25.71
1.4
1.3
g/l
6.1
6.9
1.23
63
183
(3024139) IgG subclass 3 [Mass/volume] in Serum
89
259
3.48
25.71
1.4
1.3
g/l
0.3
0.4
2.00
64
185
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
151
594
2.59
25.65
1.8
1.3
u/ml
16.8
15.3
—
6
12
(4062490)
89
260
3.47
25.56
1.4
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
91
271
3.40
25.37
3.3
3.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
91
272
3.39
25.23
1.9
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
83
234
3.59
25.16
1.9
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2824
24506
1.39
24.75
7.2
4.8
e6/l
1890.9
1528.6
0.09
43
418
(3037522) Nuclear Ab [Titer] in Serum
601
3897
1.62
24.62
1.4
1.3
titre
445.8
491.1
0.36
137
838
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
114
396
2.93
24.57
1.4
1.2
u/ml
2.5
5.5
2.33
54
169
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
128
475
2.74
24.41
1.2
1.2
u/ml
308.6
292.2
0.20
89
283
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
531
3347
1.66
24.33
3.0
2.4
u/l
28.5
38.6
4.28
453
2849
(3002582) Erythrocytes [#/volume] in Urine
1562
12325
1.40
24.31
5.5
3.5
e6/l
71.9
107.3
1.02
1332
9702
(3048929) Epstein Barr virus Ab [Presence] in Serum
159
661
2.46
24.07
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
136
525
2.64
24.01
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
776
5377
1.53
23.78
1.8
1.5
g/l
3.1
2.7
1.86
478
3118
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
91
283
3.26
23.70
1.5
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
131
502
2.66
23.48
1.3
1.3
u/l
775.0
400.4
0.35
124
474
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
904
6495
1.49
23.22
4.5
3.2
e6/l
2.3
1.6
2.16
580
3750
(3040151) Glucose [Moles/volume] in Capillary blood
129
495
2.65
23.06
7.7
8.6
mmol/l
7.5
7.5
0.06
113
392
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
88
274
3.25
22.89
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
110
390
2.86
22.87
1.3
1.3
u/l
11.9
13.3
0.22
97
354
(3009871) Measles virus Ab [Titer] in Serum
39
64
6.14
22.80
1.2
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
91
290
3.18
22.78
1.5
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2368
27222
0.74
22.77
55.6
22.5
g/l
325.6
332.1
136.88
2317
26914
(3021879) Hepatitis B virus core Ab [Presence] in Serum
317
1763
1.86
22.47
1.6
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
615
4094
1.58
22.45
2.6
2.4
ug/l
10.2
7.2
1.59
493
3512
(3044640) Blood type and Crossmatch panel - Blood
1515
12017
1.39
22.41
3.5
2.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
57
135
4.26
22.04
1.3
1.4
%
25.7
21.7
0.38
49
106
(3036782) Glucose [Moles/volume] in Pleural fluid
123
476
2.63
21.64
1.3
1.4
mmol/l
7.0
6.5
0.89
113
439
(3045788) Cell count panel - Pleural fluid
123
477
2.62
21.55
1.5
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2394
20488
1.35
21.43
5.1
3.1
u/l
66.5
56.8
3.75
2223
18564
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
184
858
2.19
21.37
1.3
1.4
g/l
0.2
0.2
0.23
166
812
(3027273) Bicarbonate [Moles/volume] in Venous blood
368
2182
1.75
21.04
6.3
3.4
mmol/l
27.6
24.9
17.89
347
2112
(3037756) Immunofixation for Serum or Plasma
211
1045
2.07
20.98
1.4
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
198
959
2.11
20.88
3.3
2.7
mg/l
2.2
1.7
7.27
174
856
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
187
889
2.15
20.70
1.4
1.4
g/l
1.2
1.2
0.17
170
841
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
198
3.52
20.43
2.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1356
10703
1.38
20.21
5.3
3.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
115
447
2.61
20.08
6.3
4.0
umol/l
349.9
340.5
0.25
101
368
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
108
409
2.68
19.86
1.3
1.2
u/ml
3.4
3.6
0.04
36
124
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2939
32474
0.74
19.81
8.6
6.6
mmol/mol
44.3
41.0
32.51
2624
29430
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
44
1621
0.26
19.70
1.7
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1613
19379
0.74
19.48
4.3
5.5
ug/l
3.0
4.3
1.21
1341
17139
(3008757) Leukocyte morphology finding [Identifier] in Blood
115
456
2.56
19.30
4.2
4.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
34
58
5.90
19.14
11.8
13.6
mmol/l
4.6
5.4
1.61
34
58
(3051611) Lipemic interference index of Serum or Plasma
108
419
2.61
18.95
7.2
3.3
—
—
—
0
0
(3035880) pH of Pleural fluid
83
282
2.98
18.69
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
149
674
2.25
18.67
3.5
3.6
%
63.5
58.5
5.13
149
674
(3023520) Reticulocytes [#/volume] in Blood
598
4112
1.52
18.67
2.4
2.5
e9/l
75.5
67.0
7.55
455
3181
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
48
114
4.24
18.53
1.4
1.6
umol/l
103.2
89.3
0.14
22
64
(3004588) Protein electrophoresis panel - Serum or Plasma
490
3237
1.57
18.31
1.9
2.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
91
331
2.78
18.12
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
55
147
3.77
18.10
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1175
9221
1.37
17.73
3.3
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1392
11214
1.34
17.70
5.3
3.4
e6/l
0.8
0.5
3.06
1172
8646
(3008295) Osmolality of Serum or Plasma
94
357
2.67
17.24
1.3
1.3
mosm/kgh2o
273.2
277.4
0.78
72
268
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
45
108
4.20
17.16
6.1
7.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
59
172
3.46
17.11
1.4
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
27
41
6.62
17.01
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3388
36445
0.74
16.99
53.7
20.4
mmol/l
4.0
4.0
11.88
3293
35387
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
125
548
2.32
16.90
3.1
2.0
mg/l
26.5
25.1
0.12
37
124
(3016879) Cocaine [Presence] in Urine
72
242
3.01
16.57
2.6
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3126
28311
1.32
16.47
12.5
7.7
u/l
84.3
81.3
1.55
3002
26449
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2005
17132
1.30
16.38
5.8
4.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
61
188
3.27
16.23
1.7
2.0
e9/l
0.3
0.2
0.58
55
170
(3019550) Sodium [Moles/volume] in Serum or Plasma
3388
36385
0.75
16.18
53.3
20.2
mmol/l
139.1
139.6
26.57
3297
35386
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
55
161
3.44
15.87
1.2
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
147
709
2.11
15.74
1.5
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
62
197
3.18
15.71
1.7
2.0
e6/l
513.5
530.6
0.08
55
170
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
45
116
3.91
15.62
4.1
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
45
116
3.91
15.62
4.1
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2796
25039
1.29
15.51
7.0
4.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
1018
0.18
15.47
1.5
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
39
91
4.31
15.44
5.7
7.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
158
793
2.03
15.22
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
63
207
3.07
15.10
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
63
207
3.07
15.10
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
359
2306
1.60
15.06
4.1
3.2
e9/l
5.3
4.2
7.04
254
1629
(21494755) Public health laboratory ask at order entry panel
35
1255
0.27
14.98
1.5
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
70
247
2.86
14.81
1.2
1.1
mmol/l
31.2
35.6
1.12
59
211
(3000764) Benzodiazepines [Presence] in Urine
73
264
2.79
14.76
2.8
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
169
3.28
14.73
3.8
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
73
265
2.78
14.66
2.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
108
476
2.30
14.47
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1638
13796
1.29
14.38
6.4
3.9
e6/l
95.7
114.2
0.34
1348
10295
(3005988) Vibrio sp identified in Specimen by Organism specific culture
108
478
2.29
14.34
1.6
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
265
1599
1.70
14.21
2.8
3.3
pmol/l
4.1
4.4
4.58
233
1368
(3027008) Opiates [Presence] in Urine
72
264
2.75
14.20
2.8
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
295
1836
1.65
14.06
1.9
2.3
g/l
4.1
3.8
0.51
201
1261
(3025468) Yersinia sp identified in Specimen by Organism specific culture
107
476
2.28
14.04
1.6
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
84
335
2.54
14.03
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
109
489
2.26
14.02
1.5
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
47
135
3.51
13.99
3.4
1.8
u/ml
245.6
29993.2
0.53
15
16
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
295
1841
1.64
13.91
1.8
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1955
16887
1.27
13.85
2.4
2.1
pmol/l
89.9
92.6
1.70
1123
8983
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
295
1843
1.64
13.85
1.9
2.3
g/l
8.2
7.4
7.87
202
1313
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
51
156
3.29
13.78
2.9
2.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
69
253
2.75
13.62
1.1
1.2
titre
200.0
104.5
0.38
11
44
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
274
1694
1.66
13.41
1.9
2.4
g/l
3.4
3.1
7.04
199
1286
(3009508) Creatinine [Moles/volume] in Urine
1495
12536
1.28
13.34
3.7
3.2
mmol/l
6.8
7.5
7.89
1205
10275
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
275
1710
1.65
13.16
1.9
2.3
g/l
9.8
10.4
1.39
222
1406
(3034426) Prothrombin time (PT)
37
94
3.96
13.14
1.2
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
414
2830
1.51
13.14
4.1
3.8
%
0.7
0.6
0.75
128
660
(3011648) Oxygen content in Venous blood
74
288
2.59
13.02
3.1
1.8
%
10.3
10.8
0.44
74
288
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
234
1400
1.71
12.96
1.8
1.7
u/l
34.8
38.0
1.42
195
1178
(3017181) Myelocytes/100 leukocytes in Blood
452
3157
1.48
12.90
4.5
3.9
%
1.1
0.9
0.66
168
953
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
16
18
8.92
12.88
2.7
1.8
mmol/l
25.8
25.6
—
10
9
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
40
5.77
12.72
4.8
4.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
85
358
2.40
12.67
1.3
1.3
nmol/l
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
50
160
3.15
12.59
1.9
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
68
259
2.65
12.51
2.9
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1548
13119
1.27
12.47
4.5
4.0
mg/mmol
19.8
9.6
6.14
1055
8447
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
32
76
4.23
12.43
5.2
7.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
104
483
2.18
12.35
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
103
480
2.17
12.13
1.6
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3281
35044
0.79
12.07
40.0
16.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
249
1544
1.65
12.06
2.0
2.4
g/l
1.0
1.2
0.23
207
1282
(3011412) CD3 cells [#/volume] in Blood
73
295
2.50
11.92
1.7
2.0
e9/l
1.3
1.0
0.98
40
175
(3004809) Band form neutrophils/100 leukocytes in Blood
136
708
1.95
11.89
3.2
3.7
%
1.2
1.5
0.76
113
515
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
94
428
2.22
11.74
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
25
51
4.92
11.67
1.2
1.2
ng/l
239.7
113.4
0.54
19
35
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
28
63
4.47
11.65
1.0
1.3
u/l
26.8
639.6
0.58
19
40
(40761535) Cells panel - Urine sediment
219
3495
0.61
11.60
3.5
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1459
12366
1.26
11.53
3.7
3.3
mg/l
479.3
333.4
0.64
1041
8018
(3037121) Protein [Mass/volume] in Urine
228
1400
1.66
11.48
3.0
3.1
g/l
0.3
0.3
0.17
111
589
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
229
1409
1.66
11.45
2.0
2.2
g/l
34.9
37.4
8.07
188
1166
(3032057) Clostridioides difficile [Presence] in Stool
37
104
3.58
11.43
2.0
1.9
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
220
1343
1.67
11.34
2.0
2.3
g/l
0.0
0.1
0.26
196
1196
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
23
45
5.13
11.25
1.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
246
1552
1.62
11.14
2.0
3.3
ratio
3.8
3.7
0.01
13
122
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
204
1228
1.69
11.09
2.0
2.3
g/l
0.0
0.0
0.00
181
1105
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
32
83
3.88
11.08
1.5
1.6
ug/l
0.3
0.4
0.92
21
46
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
250
1586
1.61
11.07
2.0
3.4
mg/l
40.5
60.6
1.35
188
1308
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1854
16213
1.24
10.93
3.5
2.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
32
5.96
10.85
1.3
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
249
1588
1.60
10.79
2.0
3.4
mg/l
55.0
95.3
0.59
188
1307
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
205
1249
1.67
10.66
2.0
2.3
g/l
0.0
0.0
1.04
181
1107
(3000570) Elastase.pancreatic [Mass/mass] in Stool
180
1061
1.72
10.58
1.5
1.4
ug/g
284.4
262.1
0.77
117
644
(3052592) Norovirus Ag [Presence] in Stool
32
86
3.74
10.56
1.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
116
599
1.96
10.43
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1631
14122
1.24
10.40
3.0
2.1
nmol/l
74.6
78.7
6.09
1393
12284
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1127
13399
0.79
10.33
5.6
4.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
197
1199
1.67
10.29
1.9
3.5
—
—
—
0
0
(4268621)
65
269
2.44
10.15
2.5
2.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
151
857
1.79
10.13
1.8
1.8
mg/l
12.0
12.5
0.20
137
781
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
46
161
2.88
9.99
1.3
1.3
ug/l
170.7
478.4
0.65
33
79
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
86
406
2.14
9.88
1.4
1.2
nmol/l
0.7
0.6
1.05
79
387
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
619
4778
1.34
9.81
5.1
4.8
%
32.7
33.2
0.52
450
3083
(3045716) Anion gap in Serum or Plasma
51
191
2.69
9.77
3.0
2.1
mmol/l
7.7
9.3
1.97
32
151
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
21
43
4.90
9.77
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
788
9731
0.77
9.76
5.7
4.2
estimate
0.0
0.0
1.28
330
3019
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
86
410
2.12
9.64
1.4
1.2
nmol/l
0.2
0.3
—
7
27
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
38
122
3.13
9.59
1.8
1.7
nmol/l
2.7
8.5
0.89
33
105
(3015377) Calcium [Moles/volume] in Serum or Plasma
1501
12974
1.23
9.52
4.1
3.4
mmol/l
2.3
2.3
3.73
1226
11078
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
133
744
1.81
9.39
1.2
1.2
u/l
37.9
43.5
0.29
100
645
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
79
369
2.16
9.35
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
2325
25479
0.83
9.33
6.4
4.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
32
94
3.42
9.30
1.0
1.1
%
99.0
92.6
0.51
25
75
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
31
91
3.42
9.03
1.0
1.0
u/ml
4.1
2.5
0.32
11
11
(3026389) Candida sp identified in Specimen by Organism specific culture
84
408
2.08
9.00
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
88
435
2.04
9.00
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
58
1283
0.45
8.98
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
692
0.26
8.85
1.6
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
142
826
1.74
8.81
1.1
1.2
titre
1068.3
1085.2
—
6
25
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
36
5.02
8.61
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
36
5.02
8.61
1.5
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
36
5.02
8.61
1.5
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
405
2988
1.39
8.53
4.7
3.9
%
0.1
0.1
0.24
162
876
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
90
458
1.98
8.51
2.2
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
49
4.30
8.39
1.4
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2810
26009
1.20
8.35
6.3
4.1
mm/h
20.2
14.1
47.42
2598
23694
(3013512) EKG study
1373
11892
1.22
8.29
6.8
4.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
24
63
3.82
8.23
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
80
396
2.04
8.19
1.4
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2517
27217
0.84
8.11
53.1
20.6
%
15.0
13.9
166.51
2451
26514
(3001019) Free T4 and TSH panel - Serum or Plasma
23
734
0.31
8.11
1.4
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
139
825
1.71
8.06
1.1
1.2
titre
311.1
91.0
—
9
49
(4034850)
55
1189
0.46
8.05
23.1
11.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
55
236
2.35
8.01
2.1
1.9
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
20
47
4.27
7.93
1.1
1.3
nmol/l
5.3
6.1
0.18
11
38
(3017354) Segmented neutrophils/100 leukocytes in Blood
86
444
1.95
7.84
2.6
3.7
%
68.3
57.9
4.30
64
257
(3015171) Extractable nuclear Ab [Units/volume] in Serum
170
1073
1.61
7.78
1.3
1.2
u/ml
0.3
0.7
—
8
102
(3041918) Cholesterol [Moles/volume] in Pleural fluid
29
91
3.20
7.65
1.1
1.2
mmol/l
1.4
1.6
0.38
21
53
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
12
18
6.68
7.60
2.8
3.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
226
1533
1.50
7.51
8.0
3.6
mmol/l
1.3
1.4
1.45
221
1510
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
384
5065
0.74
7.48
10.6
8.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
81
417
1.96
7.46
1.2
1.2
miu/ml
86.1
180.5
1.79
15
133
(3025159) Blasts/100 leukocytes in Blood
371
2765
1.37
7.36
4.7
3.9
%
0.6
0.2
0.25
140
719
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
109
621
1.77
7.33
5.0
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
555
4404
1.30
7.15
2.8
4.1
ug/l
24.4
19.8
0.20
479
3687
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
50
217
2.32
7.14
1.7
2.0
e6/l
858.9
611.0
1.05
28
94
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
29
96
3.03
7.03
2.0
2.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
20
52
3.86
6.97
1.5
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
50
220
2.29
6.93
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
612
4944
1.27
6.84
1.3
1.3
—
—
—
0
0
(4133840)
23
67
3.44
6.83
1.6
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
77
3.26
6.82
1.0
1.2
mmol/l
0.4
2.1
1.14
17
51
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
825
6901
1.24
6.80
4.4
3.0
e6/l
1.1
1.2
0.28
513
4116
(3022493) Free Hemoglobin [Mass/volume] in Plasma
41
167
2.47
6.74
5.5
4.9
mg/l
85.6
57.8
1.22
29
114
(3004616) Nuclear Ab [Presence] in Serum
76
399
1.92
6.66
1.2
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
54
3.72
6.63
1.4
1.9
e6/l
139.3
177.2
0.29
14
18
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
18
45
4.01
6.61
1.3
1.2
u/l
16.1
18.2
0.19
13
30
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
129
796
1.64
6.53
1.3
1.2
u/ml
85.4
44.0
—
6
43
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
175
2582
0.67
6.51
1.3
1.4
—
—
—
0
0
(3025315) Body weight
15
33
4.56
6.45
5.5
4.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
141
893
1.60
6.43
1.5
1.6
iu/ml
0.4
15.5
1.15
38
208
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
104
609
1.72
6.41
1.9
1.8
iu/l
3.7
4.2
0.28
38
178
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
219
3087
0.70
6.40
3.8
2.8
ml/min/173m2
50.9
60.5
3.23
108
1326
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
84
462
1.83
6.40
1.5
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
34
130
2.63
6.37
1.0
1.2
ratio
1.1
1.1
—
9
39
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
277
2016
1.40
6.37
6.6
2.5
%
0.6
0.7
2.65
271
1931
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
123
757
1.64
6.30
1.3
1.2
u/ml
3.4
6.4
0.77
19
112
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
22
5.47
6.28
1.2
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
765
9065
0.81
6.24
1.8
1.6
mmol/l
1.6
1.3
8.56
682
7456
(3020491) Glucose [Moles/volume] in Blood
56
270
2.09
6.24
3.6
1.9
mmol/l
8.1
7.0
0.93
45
185
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
121
746
1.64
6.17
1.3
1.2
u/ml
26.1
3.9
0.48
13
63
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
48
3.76
6.08
1.1
1.3
%
106.0
73.8
—
7
19
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
18
48
3.76
6.08
1.1
1.2
%
77.6
76.7
—
7
18
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
511
0.29
6.08
1.3
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
32
122
2.63
6.05
2.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
396
5042
0.77
5.98
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
84
475
1.78
5.88
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
211
2.19
5.83
1.5
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
236
1698
1.41
5.83
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
56
278
2.03
5.80
1.5
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
44
199
2.22
5.78
1.3
1.3
nmol/l
1.5
1.1
1.61
33
149
(4094501)
49
974
0.50
5.75
1.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
12
24
5.01
5.74
1.2
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
664
7904
0.81
5.61
5.1
4.3
kg/l
1.0
1.0
0.35
165
1220
(3028433) Virus identified in Specimen by Culture
30
116
2.60
5.54
1.3
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
46
217
2.13
5.46
1.3
2.0
%
13.7
16.3
0.92
30
81
(3033923) Metanephrine [Moles/time] in 24 hour Urine
21
67
3.14
5.46
1.1
1.1
umol/24h
0.8
0.7
—
9
36
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
5
16.03
5.41
1.3
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
14
34
4.13
5.35
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2930
30858
0.86
5.31
5.5
4.5
mu/l
1.9
2.1
2.03
2608
27448
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
103
635
1.64
5.31
1.3
1.2
u/ml
2.5
7.9
0.76
12
40
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
69
380
1.83
5.30
1.1
1.2
u/l
60.8
60.7
0.00
44
256
(3051593) INR in Capillary blood by Coagulation assay
52
261
2.00
5.26
4.1
13.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
87
516
1.70
5.20
1.3
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
25
92
2.73
5.09
1.1
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
53
272
1.96
5.05
1.9
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
160
1102
1.47
5.04
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
283
2150
1.34
5.03
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
20
66
3.04
4.94
2.1
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
47
235
2.01
4.83
2.3
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
45
222
2.04
4.80
1.0
1.1
u/ml
0.2
1.8
1.89
19
86
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
7
11.45
4.78
1.3
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
161
1127
1.44
4.69
1.4
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
63
352
1.80
4.66
1.6
1.6
u/ml
26.3
27.6
—
9
74
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
34
152
2.25
4.65
4.8
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
94
589
1.61
4.59
1.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
45
226
2.00
4.59
1.0
1.1
u/ml
0.8
5.0
3.35
25
97
(3000475) Leukocytes [#/volume] in Synovial fluid
139
954
1.47
4.50
1.5
1.6
e6/l
20837.3
14983.5
0.68
107
669
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
105
2.48
4.45
1.5
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
49
261
1.89
4.25
1.2
1.1
u/ml
3.6
2.4
0.20
22
101
(3000330) Specific gravity of Urine by Test strip
160
2202
0.72
4.15
5.5
3.6
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
21
79
2.67
4.15
1.4
1.2
mg/l
279.4
1.0
0.47
14
59
(3021960) Folate [Moles/volume] in Serum or Plasma
1122
10043
1.15
4.13
1.8
1.6
nmol/l
17.6
20.0
4.63
961
8498
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
44
229
1.93
4.10
1.1
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
12
32
3.76
4.08
1.8
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
53
294
1.81
4.06
1.5
1.3
titre
290.0
204.8
—
6
31
(40761539) Cells [Type] in Urine sediment by Light microscopy
26
110
2.37
4.06
1.3
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
80
2.63
4.06
1.1
1.4
%
78.9
81.0
0.07
13
51
(3044941) Cell count panel - Synovial fluid
95
617
1.55
4.03
1.5
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1607
17407
0.88
3.93
7.0
5.1
estimate
0.0
0.0
0.50
354
3249
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
70
2.72
3.91
1.1
1.1
pmol/l
281.3
247.8
0.27
12
55
(40768441) Liver Pathology biopsy report
44
233
1.90
3.91
1.6
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
84
536
1.58
3.86
1.3
1.2
u/ml
53.0
42.4
—
8
50
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
39
200
1.96
3.81
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
39
200
1.96
3.81
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
39
200
1.96
3.81
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
32
153
2.10
3.77
1.1
1.0
u/ml
1.1
2.1
0.66
21
59
(3003694) ABO and Rh group [Type] in Blood
774
8791
0.86
3.75
1.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
742
8453
0.85
3.74
3.8
3.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
27
121
2.24
3.73
2.4
1.6
—
—
—
0
0
(4146454)
76
478
1.60
3.73
2.7
2.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
39
203
1.93
3.66
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
39
203
1.93
3.66
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
39
203
1.93
3.66
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
190
1.95
3.62
1.1
1.0
u/ml
1.8
1.8
0.01
17
48
(3011985) Renin [Units/volume] in Plasma
70
437
1.61
3.55
1.3
1.4
mu/l
116.7
66.1
0.77
61
388
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
7
9
7.79
3.55
1.0
1.1
g/l
0.2
0.2
—
7
9
(3021589) Normoblasts [#/volume] in Blood
1659
15362
1.12
3.54
17.8
10.1
e9/l
0.0
0.0
0.18
1349
12452
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
14
46
3.05
3.52
1.4
1.3
ug/l
88.9
113.7
—
9
27
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
6
10.01
3.49
1.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
6
10.01
3.49
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
103
704
1.47
3.49
1.5
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
54
320
1.70
3.37
1.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
55
895
0.61
3.36
3.5
2.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
241
3027
0.79
3.33
2.8
2.1
nmol/l
12.0
11.9
0.06
193
2604
(3013727) Leukocytes other/100 leukocytes in Blood
30
148
2.03
3.30
5.8
3.6
%
59.5
55.7
0.46
30
140
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
77
2.47
3.29
1.1
1.2
%
81.2
84.0
0.11
12
47
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
128
923
1.40
3.27
2.2
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
293
2375
1.25
3.26
4.4
2.9
e6/l
0.3
0.3
0.29
288
2331
(3002331) Protein [Mass/volume] in Peritoneal fluid
22
96
2.30
3.26
1.3
1.4
g/l
27.6
27.6
0.01
17
73
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
39
213
1.84
3.21
1.6
1.4
%
63.4
67.7
0.32
32
166
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
75
489
1.54
3.20
1.6
1.5
%
69.8
64.2
0.71
53
303
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
28
3.58
3.19
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
52
310
1.69
3.19
1.5
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
15
5.34
3.19
5.3
4.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
11
6.37
3.18
9.6
5.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
23
104
2.22
3.15
1.4
1.3
%
25.0
29.7
0.30
16
66
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
73
2.47
3.12
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
64
405
1.59
3.12
1.2
1.4
pmol/l
279.8
265.9
0.09
48
309
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
1225
0.68
3.11
1.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
40
223
1.80
3.10
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
40
223
1.80
3.10
1.2
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
159
2083
0.75
3.06
2.4
2.4
—
25.9
—
0
64
(3006462) Nitrate [Presence] in Urine
35
188
1.87
3.05
4.3
4.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
16
5.01
3.05
2.0
1.3
—
—
—
0
0
(44806071)
10
29
3.45
3.04
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1625
17396
0.90
3.01
4.9
3.8
estimate
0.0
0.0
0.00
346
3208
(3023511) Choriogonadotropin [Units/volume] in Urine
16
63
2.54
2.95
1.6
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
20
88
2.28
2.93
1.1
1.2
g/l
0.3
0.3
1.56
14
64
(3000034) Microalbumin [Mass/volume] in Urine
61
389
1.58
2.90
3.1
3.2
mg/l
70.3
31.3
0.78
49
304
(3034092) Cytoplasmic Ig cells/100 cells in Blood
10
30
3.34
2.90
14.3
7.9
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
29
149
1.95
2.89
2.2
2.4
e6/l
637.2
6264.8
0.60
21
111
(3009214) Lutropin [Units/volume] in Serum or Plasma
79
535
1.48
2.87
1.2
1.3
u/l
8.6
10.1
0.58
63
433
(3014133) Dog dander IgE Ab [Units/volume] in Serum
31
164
1.90
2.84
1.1
1.0
u/ml
4.0
2.0
0.42
21
65
(3009261) Glucose [Presence] in Urine by Test strip
1655
17658
0.90
2.83
5.1
3.9
estimate
0.0
0.0
1.08
338
3120
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
13
47
2.77
2.81
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
137
1.98
2.79
1.3
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
18
4.45
2.79
2.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
563
4928
1.16
2.78
1.3
1.3
iu/ml
40.2
38.4
0.13
185
1477
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
42
247
1.71
2.75
2.4
2.1
ug/min
94.6
181.4
—
10
59
(3048879) Bone marrow aspiration report
27
138
1.96
2.74
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
382
0.47
2.74
1.1
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
14
5.01
2.72
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
333
1.60
2.70
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
167
2133
0.77
2.69
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
26
132
1.98
2.69
1.9
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
44
264
1.67
2.69
3.0
2.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
105
2.10
2.68
2.7
2.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
32
3.13
2.64
1.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
38
220
1.73
2.64
1.1
1.3
u/l
43.9
25.0
0.59
32
185
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
673
5992
1.14
2.63
1.2
1.2
u/ml
1.6
1.9
0.21
90
1498
(3011335) Digoxin [Mass/volume] in Serum or Plasma
13
49
2.66
2.62
3.5
2.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
99
714
1.39
2.60
3.1
1.5
nmol/l
1.1
0.8
1.72
81
588
(3043409) Potassium [Moles/volume] in Arterial blood
166
1295
1.29
2.59
9.5
3.8
mmol/l
4.1
3.9
4.04
146
1209
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
26
135
1.93
2.54
1.8
2.3
e6/l
27094.3
19439.8
0.15
16
81
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
12
44
2.73
2.54
2.2
2.3
—
30.7
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
10
33
3.03
2.52
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1314
14116
0.90
2.50
2.3
2.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
26
3.47
2.48
1.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
34
195
1.75
2.46
1.1
1.5
u/l
10.2
6.3
0.39
29
173
(4211845)
36
210
1.72
2.46
4.3
3.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
32
181
1.77
2.43
1.2
1.1
u/l
22.0
36.6
1.01
27
133
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
6
12
5.00
2.40
7.0
4.9
umol/l
336.8
367.1
—
6
12
(37019676) Renin [Units/volume] in Plasma --supine
6
12
5.00
2.40
1.0
1.0
mu/l
11.3
7.1
—
6
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
110
822
1.35
2.36
1.3
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
26
139
1.88
2.36
1.0
1.0
u/ml
0.6
0.3
0.21
11
40
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
38
230
1.66
2.29
1.1
1.3
u/l
119.5
95.8
0.43
32
199
(3016650) Hepatitis A virus Ab [Presence] in Serum
66
459
1.44
2.17
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
366
3165
1.17
2.16
2.2
2.1
ug/g
201.5
168.1
0.68
289
2461
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
956
8801
1.11
2.13
1.8
1.7
pmol/l
43101601.4
27955442.7
0.30
761
7115
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
69
488
1.42
2.09
1.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
5
10
5.00
2.07
1.0
1.2
s
41.7
38.0
—
5
10
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
5
10
5.00
2.07
1.6
1.0
%
3.4
2.1
—
5
10
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
38
237
1.61
2.07
1.1
1.0
mg/l
296.9
285.5
0.52
31
208
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
62
878
0.70
2.07
3.0
3.3
u/ml
99.0
808.8
1.50
48
813
(3008116) Ketones [Moles/volume] in Urine by Test strip
17
82
2.08
2.06
1.9
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
83
608
1.37
2.06
5.0
2.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
26
3.08
2.01
1.1
1.7
umol/l
9.8
17.8
—
8
26
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
145
0.34
2.01
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
17
83
2.05
2.00
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
39
248
1.58
1.97
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
242
2041
1.20
1.94
8.9
3.9
%
47.7
47.4
0.08
235
2011
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
6
16
3.75
1.93
1.0
1.1
—
37.0
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
45
2.45
1.93
1.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
191
1576
1.22
1.92
2.5
3.2
u/ml
1220.6
3092.6
0.50
167
1357
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
262
2232
1.18
1.89
2.7
2.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
33
204
1.62
1.88
1.3
2.7
%
47.6
34.4
2.87
16
76
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
52
2.31
1.87
1.5
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
39
254
1.54
1.81
1.1
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
23
3.05
1.80
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
36
2.50
1.74
1.1
1.1
umol/24h
1.8
1.9
—
9
36
(3020717) Zinc [Moles/volume] in Serum or Plasma
23
132
1.75
1.73
1.2
1.4
umol/l
13.5
24.8
2.19
23
127
(3019832) Treponema pallidum Ab [Presence] in Serum
125
998
1.26
1.73
1.8
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
24
2.92
1.72
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
134
1652
0.81
1.71
2.6
2.0
—
—
—
0
0
(4035726)
370
3269
1.14
1.68
1.5
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
21
119
1.77
1.66
2.6
2.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
62
2.10
1.65
1.5
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
341
3009
1.14
1.59
6.0
4.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
32
2.50
1.59
2.8
3.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3371
34419
0.93
1.59
46.4
16.8
mg/l
29.3
28.0
1.83
3218
28115
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
26
2.69
1.58
1.4
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
35
231
1.52
1.56
1.7
1.6
u/l
12.6
7.2
0.39
21
114
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
93
1.83
1.51
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
144
0.42
1.51
1.3
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
21
2.86
1.50
1.2
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
14
72
1.95
1.48
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
116
939
1.24
1.47
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
10
45
2.22
1.46
3.8
4.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
31
203
1.53
1.45
2.6
1.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
39
2.31
1.43
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
115
936
1.23
1.40
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
42
587
0.71
1.39
2.1
1.9
pmol/l
154.4
199.5
2.24
34
544
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
41
2.20
1.37
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
127
1051
1.21
1.33
1.9
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
370
3326
1.12
1.33
7.2
4.1
mmol/l
1.2
1.2
8.00
342
2879
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
18
2.78
1.28
3.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
27
177
1.53
1.28
1.8
1.7
—
8.8
—
0
9
(3049717) Cytology report of Urine Cyto stain
240
2106
1.15
1.27
2.8
2.8
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
48
353
1.36
1.27
1.5
1.2
u/ml
90.0
42.6
—
5
19
(40768443) Skin Pathology biopsy report
190
1640
1.17
1.26
1.3
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
25
2.40
1.24
1.5
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
25
2.40
1.24
1.5
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
36
2.22
1.24
1.1
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
64
494
1.30
1.23
1.3
1.6
mu/l
301.0
285.7
0.17
59
455
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
26
171
1.52
1.23
1.2
1.3
u/l
17.3
30.3
1.69
19
141
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
25
163
1.54
1.22
1.8
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
8
37
2.16
1.21
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
51
383
1.34
1.19
2.2
2.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
29
197
1.48
1.19
2.2
2.6
ml
1980.1
1789.6
0.16
23
161
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
112
929
1.21
1.18
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
37
265
1.40
1.16
1.3
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
240
1.42
1.15
1.8
1.8
u/field
4.0
2.2
0.47
24
163
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
87
1.73
1.15
1.2
1.5
%
4.0
5.5
—
10
42
(3010144) Erythrocytes [#/volume] in Synovial fluid
51
386
1.32
1.14
1.3
1.3
e6/l
211738.6
93509.1
0.26
25
262
(3022689) Creatine [Moles/volume] in Urine
17
103
1.65
1.12
2.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
30
2.34
1.12
5.1
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.4
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
143
1.54
1.11
1.1
1.3
umol/l
5.4
12.2
0.85
16
89
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2417
24802
0.95
1.10
4.3
3.7
pmol/l
15.2
15.0
2.67
2149
21942
(40768793) Breast Pathology biopsy report
39
526
0.74
1.09
1.6
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
5
21
2.38
1.09
1.2
1.0
u/field
1.2
0.9
—
5
15
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
41
1.95
1.08
1.7
1.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
23
152
1.52
1.08
2.1
2.1
umol/l
62.7
54.6
0.80
17
116
(3036670) Protein [Mass/volume] in Synovial fluid
21
137
1.54
1.05
1.2
1.2
g/l
40.0
40.4
0.05
11
70
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
80
651
1.23
1.04
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
90
1.67
1.04
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
820
0.80
1.01
2.1
1.7
mg/l
19.1
3.6
3.72
60
589
(40765096) Chromosome analysis panel by Banding
7
135
0.52
0.98
1.3
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
36
1.95
0.97
1.6
1.1
u/l
14.4
11.3
—
7
36
(3002523) Influenza virus A Ag [Presence] in Specimen
36
267
1.35
0.96
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
51
1.77
0.94
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
27
2.22
0.93
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
94
1.60
0.90
1.2
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
94
1.60
0.90
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
94
1.60
0.90
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
94
1.60
0.90
1.2
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
29
2.07
0.89
1.0
1.9
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
7
129
0.54
0.87
1.3
1.2
%
56.8
66.1
—
7
106
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
170
1.41
0.85
1.2
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
344
0.73
0.84
1.2
1.2
mmol/l
8.3
7.8
0.29
14
245
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
88
1.59
0.84
1.0
1.1
miu/ml
1370.5
1600.0
0.35
14
88
(3044290) Cell count panel - Cerebral spinal fluid
75
624
1.21
0.83
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
89
753
1.19
0.83
2.3
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
46
1.74
0.82
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
736
6990
1.06
0.81
6.2
4.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
59
482
1.23
0.79
1.1
1.1
iu/ml
20.8
58.8
0.83
16
96
(3023323) Follitropin [Units/volume] in Serum or Plasma
51
410
1.25
0.79
1.3
1.3
iu/l
33.1
31.2
0.17
44
349
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.3
—
37.8
—
0
13
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.5
—
0.7
—
0
16
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.1
—
48.5
—
0
25
(1617658) Protocol used for examination of sentinel lymph nodes
12
186
0.64
0.76
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
23
313
0.73
0.75
1.6
1.9
ug/l
2.2
3.6
1.23
18
270
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
75
1.60
0.74
1.7
1.4
ug/l
13.5
9.6
0.70
12
75
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
12
75
1.60
0.74
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
72
606
1.19
0.73
2.1
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
25
2.00
0.72
1.4
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
22
159
1.39
0.72
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
168
1.37
0.71
1.1
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
40
1.75
0.71
1.3
1.2
—
744.7
—
0
7
(21494890) Protein electrophoresis panel - 24 hour Urine
60
500
1.20
0.69
1.7
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
97
843
1.15
0.69
1.6
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
91
0.55
0.67
1.8
3.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
43
1.63
0.66
1.4
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
179
1.34
0.66
1.1
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
29
223
1.30
0.66
1.9
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
109
1233
0.88
0.64
5.6
4.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
29
1.72
0.64
2.6
3.9
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
18
129
1.40
0.63
1.8
2.7
umol/l
28.1
29.2
0.10
11
94
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.3
—
19.7
—
0
13
(44806420)
11
163
0.67
0.60
1.6
2.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
53
1.51
0.58
2.4
2.9
u/field
0.1
0.2
—
8
53
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
53
1.51
0.58
1.4
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
176
1.31
0.56
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
55
1.46
0.56
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
221
1.27
0.55
6.8
3.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
46
386
1.19
0.53
1.6
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
169
1.30
0.53
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
169
1.30
0.53
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
35
286
1.23
0.52
1.7
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
31
250
1.24
0.52
1.3
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
40
1.50
0.51
2.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
57
657
0.87
0.48
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
47
400
1.18
0.48
1.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
32
263
1.22
0.47
2.1
1.9
min
487.3
492.1
0.07
19
182
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
50
1.40
0.45
1.4
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
218
0.78
0.42
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
30
360
0.83
0.42
1.1
1.1
—
11.1
—
0
14
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
140
1.29
0.41
1.2
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.2
—
1.7
—
0
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
17
0.00
0.40
0.0
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
123
1.30
0.40
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
81
898
0.90
0.40
1.3
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
150
1.27
0.40
1.7
1.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
130
1202
1.08
0.38
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
89
1.35
0.37
2.7
5.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
333
0.84
0.37
1.3
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
70
1.29
0.36
2.1
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
32
375
0.85
0.36
1.8
1.4
%
26.9
24.2
0.17
21
231
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
172
1.22
0.34
1.0
1.1
—
—
—
0
0
(3015736) pH of Urine
1339
13626
0.98
0.32
4.1
3.6
—
5.8
—
0
18
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
117
1089
1.08
0.31
2.0
3.7
u/ml
60.9
73.7
0.34
111
1050
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
111
1.26
0.30
1.3
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
118
1104
1.07
0.29
2.2
2.3
ug/min
220.8
95.2
0.88
62
651
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
183
0.82
0.27
1.8
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
28
243
1.15
0.26
1.8
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
66
1.21
0.26
1.0
1.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
22
187
1.18
0.26
1.4
1.4
%
1.0
2.6
—
5
43
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
42
376
1.12
0.26
1.7
2.0
u/field
1.2
1.5
0.29
20
144
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
235
0.85
0.25
1.6
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
181
0.83
0.25
1.8
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
656
1.08
0.25
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
14
115
1.22
0.23
1.9
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
65
601
1.08
0.23
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
94
1001
0.94
0.23
1.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
762
7474
1.02
0.23
3.4
3.1
mmol/l
2.5
2.5
14.74
597
6495
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
97
1.24
0.22
1.3
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
88
1.25
0.22
1.1
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
93
0.75
0.22
1.1
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
98
1.23
0.21
1.3
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
27
303
0.89
0.20
1.1
1.1
u/ml
10.1
2.3
—
5
92
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
90
1.22
0.19
1.3
1.1
—
—
—
0
0
(4027681)
15
128
1.17
0.18
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
34
309
1.10
0.18
1.6
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
60
1.17
0.17
13.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
91
1.21
0.17
1.8
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
145
1509
0.96
0.17
1.2
1.2
iu/ml
87.5
133.9
0.78
38
501
(3045142) Bone marrow Pathology biopsy report
46
496
0.93
0.17
1.1
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
85
806
1.06
0.17
1.2
1.3
mg/l
523.8
605.2
0.76
76
756
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
66
0.76
0.17
1.8
2.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
67
0.75
0.17
2.0
2.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
8
72
1.11
0.16
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
32
293
1.09
0.15
1.2
1.1
—
23.7
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
102
1.18
0.15
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
305
3118
0.98
0.14
1.6
1.5
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
12
103
1.17
0.13
2.4
2.4
mmol/l
7.8
7.6
—
7
64
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
110
0.82
0.13
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
158
0.89
0.12
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
114
1.14
0.11
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
912
9032
1.01
0.11
5.3
3.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
172
1.11
0.11
2.0
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
308
1.07
0.11
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2944
29543
0.99
0.11
46.4
18.4
%
37.3
38.7
7.20
1658
18285
(3047189) Immunofixation for 24 hour Urine
22
239
0.92
0.10
1.5
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
251
2555
0.98
0.09
4.6
3.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
19
174
1.09
0.09
4.1
6.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
126
1.11
0.09
1.2
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
113
0.88
0.08
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
224
1.07
0.08
1.3
1.2
mmol/l
13.0
11.9
0.38
14
75
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
2.4
3.1
mg/l
5.2
6.3
—
5
55
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
67
1.04
0.08
1.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
76
1.05
0.07
1.3
1.6
ng/l
129.7
161.6
—
8
76
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
108
1.11
0.07
1.4
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
(4281824)
32
305
1.05
0.06
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
256
1.06
0.06
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
393
3896
1.01
0.05
1.2
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
73
714
1.02
0.04
1.2
1.2
mmol/l
4.2
3.9
1.13
63
659
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
91
1.10
0.04
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
85
866
0.98
0.04
5.1
3.7
mg/l
38.3
31.0
0.81
52
557
(1002224) Polysomnography panel
88
864
1.02
0.04
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
317
3193
0.99
0.03
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
468
4654
1.01
0.03
1.2
1.2
u/ml
61.5
12.4
1.29
101
1647
(3037556) Urate [Mass/volume] in Serum or Plasma
15
141
1.06
0.03
1.3
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
112
1.07
0.03
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
37
380
0.97
0.02
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
39
380
1.03
0.02
1.3
1.2
nmol/l
281.4
323.0
0.58
26
296
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
69
679
1.02
0.02
1.5
1.4
e6/l
1230.7
813.4
0.18
55
558
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
69
680
1.01
0.02
1.4
1.3
e6/l
9.8
23.7
0.77
53
534
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
127
0.94
0.01
1.3
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
127
1260
1.01
0.01
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
32
313
1.02
0.01
1.2
1.1
—
0.8
—
0
5
(3016228) CD19 cells/100 cells in Blood
14
134
1.04
0.00
1.3
2.0
%
7.0
8.0
0.16
14
126
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
112
0.98
0.00
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
81
808
1.00
0.00
1.5
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
34
336
1.01
0.00
1.9
1.8
mg/l
5.2
4.9
0.16
29
318
(44813793)
15
149
1.01
0.00
1.0
1.0
—
—
—
0
0
(4024509)
39
389
1.00
0.00
1.6
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
39
391
1.00
0.00
2.2
2.1
ml
619.9
644.0
0.15
24
235
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.6
—
0
6
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.6
1.8
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
160
1.00
0.00
1.0
1.4
nmol/l
0.2
0.2
0.45
11
122
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
92
0.98
0.00
1.3
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
12.0
—
0
8
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
9
89
1.01
0.00
1.0
2.0
ug/l
3.1
1.0
—
9
82
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
89
1.01
0.00
1.2
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
1468.8
—
0
8
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
2488.6
—
0
7
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
80
1.00
0.00
1.1
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint COPD_INSUFFICIENCY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| COPD_INSUFFICIENCY | 7.189 [6.29, 8.22] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.291 |
During the follow-up period (1.1.1998 — 31.12.2019), 4637 out of 7596 females with COPD_INSUFFICIENCY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| COPD_INSUFFICIENCY | 5.878 [5.05, 6.84] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 9064 out of 14020 males with COPD_INSUFFICIENCY died.
Mortality risk
Mortality risk for people of age
years, who have COPD_INSUFFICIENCY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.727% | 1.087% |
| 5 | 4.208% | 6.526% |
| 10 | 9.328% | 16.135% |
| 15 | 17.705% | 27.548% |
| 20 | 30.526% | 42.135% |
Relationships between endpoints
↥Index endpoint: COPD_INSUFFICIENCY – COPD-related respiratory insufficiency
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data